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Active Site Studies of Arogenate Dehydrogenase and the Purification of its Substrate 
Natalie Rachel 
Arogenate dehydrogenase (AD) from the cyanobacterium Synechocystsis sp. 
PCC6803 is one enzyme within the family of TyrA proteins dedicated to the biosynthesis of 
L-tyrosine (L-Tyr) and catalyzes the NADP+-dependant oxidative decarboxylation of L-
arogenate to L-Tyr.  To circumvent some of the difficulties in obtaining L-arogenate using 
current methodology, we developed an improved methodology to synthesize L-arogenate 
enzymatically using the recently annotated prephenate aminotransferase from Petunia 
hybrida. L-arogenate was then purified from major contaminants by high performance liquid 
chromatography. Guided by sequence alignments and the crystal structure of AD, residues 
were targeted for the first mutagenesis experiments on this enzyme; the variant proteins were 
characterized by kinetic, biophysical and computational methods. We identified that His112, 
a highly conserved residue, is the catalytic hydrogen bond acceptor and is critical for enzyme 
function, whereas electrostatic interactions afforded by Asp171 appear critical for the overall 
stability of the enzyme.  Both Arg213 and Arg217, a highly conserved residue, appear to play 
a role in enzyme function, which contradicts the conclusion inferred from the crystal 
structure. His170, was also identified to be an important active site residue, and likely 
maintains His112 in a catalytically competent conformation via hydrogen bonding. Ser178, 
His179, T117 and Gly221 were all also found to be important for enzyme function. Even 
though the exact roles of these residues require further clarification, our studies have 
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Chapter 1: Introduction 
1.1 Aromatic Amino Acids Biosynthesis 
The aromatic amino acids L-tyrosine (L-Tyr), L-tryptophan (L-Trp) and L-
phenylalanine (L-Phe) are critical for the growth and survival of all living organisms. 
They are essential components for protein synthesis, but they also serve as precursors for 
a number of important aromatic metabolites such as flavonoids (1), quinones (2,3), 
cyanogenic glycosides (4) and alkaloids (5,6). Unlike mammals, who require these 
essential amino acids from their diet, archae- and eubacteria, fungi and plants have the 
ability to synthesize them. The metabolic pathways involved in this synthesis are the 
“shikimate” and the “phenylpyruvate/4-hydroxyphenylpyruvate (PP/HPP)” or 
“arogenate” pathways. Considering the absence of these metabolic pathways in 
mammals, these enzymes are targets for the design of inhibitors that can act as herbicides, 
fungicides or antimicrobial agents (7,8). Furthermore, many of these enzymes are of 
interest to the food, pharmaceutical, and agricultural industries as their products can serve 
as precursors for the synthesis of commercially valuable compounds such as drugs and 
biodegradable polymers (9, 10, 11, 12).  
The shikimate pathway (Figure 1) links carbohydrate metabolism to the biosynthesis 
of aromatic compounds (13,14). In this pathway, glucose and other six-carbon sugars are 
converted through a series of seven enzymatic steps to chorismate, which then serves as a 
branch point for the biosynthesis of several intermediates.  The first reaction of the 
pathway is the condensation of erythrose-4-phosphate and phosphoenolpyruvate, to yield 
the seven-carbon compound 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP). 
The reaction is catalyzed by 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase 
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(DAHP synthase), whose isozymic forms are sensitive to regulation by each of the 
aromatic end products.  In the steps that follow, DAHP is cyclised to yield shikimate, 
which is then converted to chorismate. 
 
Figure 1: The pathway for aromatic amino acid biosynthesis. The shikimate pathway consisting of the 
first seven enzyme-catalyzed steps ending in the production of chorismate; DAHP denotes 3-deoxy-D-
arabino-heptulosonate. 
The remaining biosynthetic steps leading to L-Tyr and L-Phe can occur by two 
possible routes, shown in Figure 2. First, chorismate undergoes a Claisen rearrangement 
to the common intermediate, prephenate. This reaction is catalyzed by chorismate mutase 
(CM). Prephenate is then either oxidatively decarboxylated by prephenate dehydrogenase 
(PD) in the presence of NAD
+ 
to form p-hydroxyphenylpyruvate (HPP) and carbon 
dioxide, or dehydrated and decarboxylated by prephenate dehydratase (PDT) to form 
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phenylpyruvate (PP). HPP or PP are then transaminated to form L-Tyr or L-Phe, 
respectively. This branch of the pathway is known as the “HPP/PP pathway”.  In the 
“arogenate pathway”, prephenate is transaminated by prephenate aminotransferase (PAT) 
using either L-glutamate or L-aspartate as amino donors, yielding L-arogenate. L-
arogenate is then either oxidatively decarboxylated by arogenate dehydrogenase (AD) in 
the presence of NADP
+
 to form L-Tyr and carbon dioxide, or dehydrated by arogenate 
dehydratase (ADT) to form L-Phe. Both amino acid end products function as feed-back 
inhibitors of the CM-catalyzed reaction; this inhibition is also observed with PD, PDT, 
and some AD and ADT enzymes. The focus of this study is on the reaction catalyzed by 
AD, shown in bold and red (Figure 2).
 
Figure 2: Biosynthesis of L-tyrosine and L-phenylalanine by the phenylpyruvate/4-
hydroxyphenylpyruvate (PP/HPP) pathway and the L-arogenate pathway. 
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1.2 The TyrA Protein Family 
The TyrA protein family consists of enzymes that catalyze a cofactor-dependent 
irreversible decarboxylation step in a terminal step in L-Tyr biosynthesis. These 
homologous dehydrogenases are categorized according to their substrate specificity (15, 
16). The two cyclohexadienyl substrates that are accepted by TyrA proteins are either 
prephenate or L-arogenate. Prephenate and L-arogenate are structurally very similar; the 
pyruvyl side chain in prephenate is replaced by an alanyl group in L-arogenate. Despite 
this similarity, most TyrA proteins are highly exclusive to either prephenate or L-
arogenate. TyrAp proteins exclusively decarboxylate  prephenate to yield HPP; TyrAa 
proteins exclusively decarboxylate  L-arogenate to yield L-Tyr, and TyrAc proteins are 
promiscuous for either prephenate or L-arogenate. In addition to their selected 





 as a nucleotide cofactor (15). Generally, TyrAp dehydrogenases prefer NAD
+
 as 
a co-substrate, while TyrAa dehydrogenases prefer NADP
+
 (17, 18). The different TyrA 
categories are also generally linked to specific organisms, as deduced through extensive 
phylogenetic analysis and sequence alignments (reviewed by Jensen and colleagues (16, 
27)): bacteria and yeast are hypothesized to possess TyrAp or TyrAc activity, while plants 
and a few bacteria (such as cyanobacteria) possess TyrAa activity. 
As TyrA proteins are always responsible for the terminal decarboxylation step in L-
Tyr biosynthesis, they all share a core catalytic domain of approximately 30 kDa, are 
catalytically active as dimers, and maintain the same fundamental reaction group 
chemistry. However, a number of TyrA proteins are multi-functional due to the presence 
of fused domains. Some examples of bifunctional TyrA proteins are as follows: PDs from 
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E. coli and Haemeophilus influenza, which are coupled with CM activity associated with 
the N-terminal region of the protein (19); PDs from Pseudomonas fluorescens and 
Acinetobacter calcoaceticus are bifunctional with phosphoshikimate 
carboxyvinyltransferases activity at the proteins’ C-terminal portion (20). Trifunctional 
PDs also exist, as seen in Nanoarchaem equitans and Archaeoglobus fulgidus (21); these 
enzymes possess CM, PD, and PDT activities in separate domains. This work is primarily 
interested with the monofunctional TyrA proteins, examples of which include:  PDs from 
Aquifex aeolicus (22) and Bacillus subtilis (23), ADs from Nicotiana silvestris (24) and 
Synechocystis sp. (15), and the cyclohexadienyl dehydrogenases from Pseudomonas 
stutzeri (23) and Zymomonas mobilis (26).  
 Despite the existence of TyrA proteins in many different bacteria, fungi, and 
plants (15, 27), relatively few have been purified and characterized. The most well 
characterized TyrA protein is the bifunctional CM-PD from E. coli; the kinetic and 
biophysical properties of both wild-type and variant forms have been reported (19, 28, 
29, 30), although there is no crystal structure available for the bifunctional enzyme. 
Another well-characterized TyrAp protein is PD from the hyperthermophilic bacterium 
Aquifex aeolicus (22). The crystal structure was determined both in the presence and 
absence of product and product analogs, and is the only monofunctional TyrAp 
structurally well characterized to date (31). TyrAp proteins from Streptococcus mutans 
(32) and Mycobacterium tuberculosis (33) have also been studied, while TyrAc from Z. 
mobilis and Pseudomonas strutzeri are twp of the only TyrAc proteins to have been 
characterized (23, 26, 27). From the TyrAa protein class, isozymic forms from 
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Arabadopsis thaliana have been reported (56) and the crystal structure and some kinetic 
data is available for AD from Synechocystis sp (15, 48). 
 
1.3 The Active Sites of the Bifunctional CM-PD from E.coli 
CM-PD from E. coli is a homodimer with a molecular weight of ~ 42 kDa per 
monomer. In the absence of a crystal structure, residues that compose each domain were 
determined by aligning the primary amino acid sequence of the enzyme with that of E. 
coli CM-PDT. It was found that the first 109 amino acids of the sequence likely encode 
the CM domain of the enzyme, while the remaining 277 residues constitute the PD 
domain. Initial kinetic and protein chemistry studies on CM-PD supported the hypothesis 
that both CM and PD activities occur at a common active site. (34, 35) More recent 
studies, however, have suggested that the enzyme maintains two separate active sites for 
each reaction; both the CM and PD activities were independently inhibited by substrate 
analogs that mimic the transition states of the CM and PD reactions (28, 35). This 
hypothesis was further enforced by mutagenesis studies whereby K37A and H197N 
variants were reported to selectively abolish CM and PD activities, respectively (36, 37).   
Studies also support the idea that the two active sites may be structurally and functionally 
interdependent.  NAD
+
, the cofactor for the PD-catalyzed reaction, activates the mutase 
reaction (19). Efforts to genetically separate CM-PD’s two domains have lead to proteins 
that are inactive or unstable (81). Several site-specific replacements in the dehydrogenase 
domain also affect mutase activity; for example, the K178R, H189N, R286A variants 
were found to have reduced CM and PD activities (37).  
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Mutagenesis studies on E. coli CM-PD have also helped to identify residues that are 
critical for chorismate and prephenate binding (37), although most mutagenesis work on 
CM is reported for the independently expressed mutase domain from E. coli CM-PDT, 
guided by a crystal structure of the “mini-mutase” bound with a transition-state analog 
(82). The residues involved in prephenate binding, however, are of particular interest in 
the present study. For example, K178R and R294Q variants from CM-PD were reported 
to have increased the Km for prephenate 36- and 120-fold, respectively (37). Additionally, 
both cationic residues are conserved amongst all TyrA proteins (Figure 4). 
 
1.4 Proposed Mechanism of the Prephenate and Arogenate Dehydrogenases 
The proposed catalytic mechanism for the prephenate dehydrogenase reaction is 
shown in Figure 3. In PDs, prephenate is oxidatively decarboxylated in a NAD
+
-
dependant reaction, to form HPP and carbon dioxide. Similarly, in ADs, arogenate is 
decarboxylated in a NADP
+
-dependant reaction, to form L-Tyr and carbon dioxide. The 
formation of the aromatic products is the driving force of this irreversible reaction. There 
are two chemical processes that must occur in this reaction: first, the ring carboxyl group 
must leave to form carbon dioxide, and second, the subsequent hydride transfer from the 
C-4 of prephenate to the C-4 of the nicotinamide ring of the cofactor. 
13
C and deuterium 
kinetic isotope studies on E. coli CM-PD, which monitor the cleavage of the C-C bond in 
the decarboxylation step, revealed that for this enzyme-catalyzed reaction, these two 
steps occurred concomitantly (38). 
In order to help identify the residues involved in the PD-catalyzed reaction of E. coli 




Figure 3: Proposed mechanism for the prephenate dehydrogenase reaction. Prephenate and NAD
+
 
bind to different cavities at the active site of PD domain. His197, a deprotonated group with pKa value of 
6.5 is believed to assist hydride transfer from 4-hydroxyl group of prephenate to NAD
+
 and concomitant 
decarboxylation by polarizing prephenate’s 4-hydroxyl group. This and the formation of aromatic product, 
HPP, provide the driving force to lower the activation energy barrier. Arg294 was proposed to interact with 
the ring carboxylate of prephenate bound to the enzyme-NAD
+
 complex. In addition, another protonated 
group (identity unknown) with pKa value of ~8.8 is believed to interact with the pyruvyl side chain of 
prephenate to lock prephenate in the active site. This mechanism was proposed by Christendat and Turnbull 
(36,37).  
 
profiles (29, 36, 38). The variation of log V/Et as a function of pH identified one 
ionisable group (pKa 6.8) which must be deprotonated for maximum activity and is 
involved in catalysis and/or product release (38). However, the plot of (V/Et)Kprephenate vs. 
pH indicated the presence of another residue, with a pKa value of ~8.8,  involved in the 
binding of  prephenate to the enzyme-NAD
+
 complex. The identity of this residue has yet 
to be determined.  The catalytic residue, however, was identified by chemical 
modification and site-directed studies as H197 (25, 30, 36).The PD activity of the H197N 
variant was dramatically reduced, while CM activity was unaffected (36). Interestingly, 
and the Km for prephenate and NAD
+





 Figure 4: Multiple sequence alignment of AD and PD domains of TyrA proteins. The sequences of the 
following species are listed: Bifunctional CM-PDs from Escherichia coli and Haemophilus influenzae, 
Streptococcus pneumoniae, Bacillus subtilis, Zymomonas mobilis, Aquifex aeolicus, Heliobacter pylori, 
Synechocystis sp., and Saccharomyces cerevisiae. Residues conserved to identitiy are highlighted in 
yellow, and include the catalytic H-bond acceptor (H112 in Synechocystis sp.) and the cationic arginine 
interacting with prephenate`s carboxylate group in PD enzymes (R217 in Synechocystis sp.) Residues 




 the  values reported for wild-type enzyme, suggesting that H197 is involved solely in 
catalysis. H197 is also a highly conserved residue in the TyrA proteins (Figure 4). 
Another conserved residue, R294, was found to be critical for the binding of prephenate 
to the enzyme-NAD
+
-complex , as the R294 to glutamine replacement increased the Km 
for prephenate  by 120-fold without affecting catalysis (37). Further studies with 
inhibitory substrate analog studies were carried out in order to probe R294’s interaction 
with prephenate. A series of HPP analogues, all missing the ring carboxyl group,  were 
found to have similar dissociation constants for wild-type enzyme and the R294Q variant 
(37), suggesting that an electrostatic interaction exists between the arginine and the ring 
carboxylate. This finding contradicts the hypothesis of Hermes et al. (38), in which they 
proposed that the ring carboxyl group might reside in a hydrophobic pocket in order to 
promote decarboxylation concomitant hydride transfer. 
 
1.5 Crystallographic Studies on Different TyrA Proteins 
It is only recently that crystallographic data has become available to guide 
mutagenesis studies on TyrA proteins. In 2006, Christendat, Turnbull and colleagues (31) 
reported the first crystal structure of a TyrA protein; an N-terminally deleted variant of A. 
aeolicus PD (Δ19PD) was co-crystallized with NAD+ at pH 3.2, yielding crystals that 
diffracted to 1.9 Å resolution (22, 40). It was not until 2009, however, that the same 
authors reported the structures of Δ19PD in complex with NAD+ plus either L-Tyr (at 
2.21 Å), HPP (at 2.15 Å) or hydroxyphenyl proprionate (at  2.25 Å) (31). Also in 2006, 
and pertinent to the present study, Legrand et al. reported the first structure of AD from 
Synechocystis sp in complex with NADP
+
, at a resolution of 1.55 Å (48). Its diagram is 
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shown in Figure 5.  Since then, two other PDs have been crystallized but in the absence 
of any ligands and their structures reported – that of PD from Streptococcus thermophilus 
at 2.46 Å resolution in 2008, and PD from Cornyebacterium glutamicum at 2.60 Å 
resolution in 2010.  The most recent crystal structure is that of a variant of H. influenzae 
CM-PD (Δ80 CM-PD) in which the first 80 residues of the CM domain had been 
genetically deleted and the protein recombinantly expressed in E. coli. The structure of 
Δ80 CM-PD in complex with NAD+ and L-Tyr was reported at a resolution of 2.0 Å (47).   
 
Figure 5: Crystal structure of Synechocystis sp AD complexed with NADP
+
, pH 8.0.  The two 
monomers are coloured in blue and burgundy. Each monomer can be divided into a N-terminal 
dinucleotide-binding domain and a C-terminal dimerization domain, which have been labelled. NADP
+
 is 
represented as green sticks. This figure was created using PyMOL (44). 
 
Despite having moderately low sequence identity, the crystallized TyrA proteins 
display remarkably similar overall structural folds. The sequence identity between 
Synechocystis sp AD and A. aeolicus PD is only 29%, but the monomers of the NADP
+
-
bound AD and NAD
+
-tyrosine-bound Δ19PD have a backbone RMSD alignment of 1.3 
Å. As such, the structures of A. aeolicus Δ19PD have been utilized to facilitate modelling 
and ligand docking studies in this thesis.  The level of identity of AD with the other PDs 
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and the PD domain of bifunctional CM-PDs are all very similar: Synechocystis sp AD 
shares 26% identity with H. influenzae CM-PD, 23% with E. coli CM-PD, 28% identity 
with C. glutamicum PD, and 31% with S. thermophilus PD. The two enzymes that share 
the highest sequence identity, at 57%, are the CM-PD enzymes from E. coli and H. 
influenzae. The structure of H. influenzae Δ80 CM-PD is currently being used in the 
Turnbull lab to guide further mutagenesis studies on CM-PDs from E. coli and H. 
influenzae. 
A representative structure of AD from Synechocystis sp in complex with NADP
+
 is 
shown in Figure 5. The enzyme is dimeric and comprised of identical monomers 
containing a C-terminal dimerization domain, and an N-terminal nucleotide binding 
domain. Each monomer contains one active site, which is located at the interface of the 
two domains and encompasses amino acids from both monomers. The overall geometry 
of the active site between the five crystallized enzymes is reasonably well conserved, 
particularly with respect to several residues that have been identified to be important for 
binding and catalysis in both E. coli CM-PD and A. aeolicus PD. 
 
1.6 Prephenate Dehydrogenase from Aquifex aeolicus 
A. aeolicus is a microaerophilic, hydrogen-oxidizing, obligate chemolithautotroph 
organism, originally isolated from thermal vents found in Yellowstone National Park and 
can thrive at temperatures up to 95 °C.  Its genome was sequenced (39) revealing the 
identity of a putative tyrA gene, which was predicted to encode a protein of 311 residues. 
The protein was recombinantly expressed in E. coli and both the full-length and 
crystallisable Δ19PD forms have been kinetically and biophysically characterized (22),
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confirming that they are thermophilic PDs. The enzyme has an absolute requirement for 
NAD
+
 as a cofactor and prefers prephenate as the cyclohexadienyl substrate to L-
arogenate by a factor of 241-fold (22). Both the full-length and Δ19PD forms are 
sensitive to feedback inhibition by L-Tyr. 
 To gain further insight into the role of active site residues in substrate binding and 
catalysis, Bonvin (22), Hou (43) and Hotz (42) completed the first site-directed 
mutagenesis studies on Δ19PD, guided by sequence alignments and the available crystal 
structures of the enzyme bound with NAD
+
 and in complex with NAD
+
 and HPP or L-
Tyr (Figure 7)). Given the structural similarities between prephenate, L-arogenate and L-
Tyr, it was hoped that such studies might also shed light on the factors that determine 
substrate specificity in TyrA proteins. The residues that are summarized here are of 
particular interest in this study, as they are all conserved in Synechocystis AD, and 
subjected to investigation by mutagenesis. 
The results from the mutagenesis studies revealed that a number of residues were 
important for catalysis, particularly H147 and H205. H147 was identified as the catalytic 
hydrogen bond acceptor in the reaction (H197 in E. coli CM-PD) (31); the H147N variant 
was found to be inactive, but maintains an apparent affinity for prephenate similar to that 
of the wild-type enzyme. The structures of liganded Δ19PD also revealed that H205 is 
within hydrogen bonding distance of H147.  Accordingly, the H205L variant was 772-
fold less active than wild-type enzyme, suggesting that this replacement perturbs the 
correct orientation of H147 within the active site.  
Other residues were identified to play a role primarily in prephenate binding without 
affecting catalysis or the binding of NAD
+
 (R250, K246’, T152). Two cationic residues, 
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R250 and K246’, when replaced with alanine individually, resulted only in a 10-fold and 
20-fold increase in Km for prephenate, respectively (42, 43).  This was especially 
surprising for R250A since replacement of the homologous residue in E. coli CM-PD 
(R294Q) resulted in over a 100-fold increase in Km for prephenate (37).  Although, not 
critical for prephenate binding individually, presumably R250 and K246’ might act in 
concert, as the Km for prephenate of the double variant was increased by 221-fold (42). 
Docking prephenate into the active site of the NAD
+
-bound crystal structure (42) 
revealed that these two residues likely form electrostatic interactions with prephenate: 
K246 with the ring carboxyl group, and R250 with the chain carboxyl group (Figure 6). 
T152 resides on a flexible loop in the active site, and interacts with NAD
+
 in the crystal 
structure of PD. Docking experiments with prephenate revealed a potential hydrogen 
bond with the backbone amine of T152 (42). Additionally in the L-Tyr and NAD
+
-bound 
crystal structure, the amine of L-Tyr was found to have an interaction with the backbone 
carbonyl group of T152 (Figure 7). 
Many TyrA proteins, including AD from Synchocystis sp, maintains a conserved SH 
pair in the active site.  In A. aeolicus PD, S213 is thought to be important in the binding 
of prephenate by helping to position a conserved water molecule, WAT1, near the C-4 
hydroxyl group of the substrate or product HPP (Figure 7).  WAT1 is coordinated though 
a network of hydrogen bonds involving S213, H214, H217,and the substrate’s hydroxyl 
group. S213’s role in binding was confirmed when the S213A variant displayed a 21-fold 
increase in Km for prephenate, without affecting NAD
+
 binding. Mutagenesis studies also 
revealed that of the SH pair, S213 is the more important than H214 for this interaction 
(42). Finally, D206, a residue conserved in all TyrA proteins, was found to be critical for 
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enzyme function. The D206A variant displayed no detectable activity as well as a 
significantly reduced yield when expressed and purified, relative to the wild-type enzyme 
and other variants (42). 
 
 
Figure 6:  Selected active site residues of A. aeolicus Δ19PD complexed with NAD+ at pH 3.2 with 
prephenate modeled in the active site. The primed residues denoted those groups associated with the 





Figure 7: Selected active site residues of A. aeolicus Δ19PD complexed with NAD+ and (A) HPP or (B) L-Tyr at pH 7.8. Pictures created using PyMOL 




1.7 Contrasting L-Tyrosine Feedback Inhibition in E. coli and H. influenzae CM-PD 
and A. aeolicus PD 
Many TyrA proteins are at a branch point in the pathways for the biosynthesis of L-
Phe and L-Tyr; the ability to regulate enzyme activities is necessary for shunting 
metabolites to the appropriate aromatic amino acid end product. Thus, certain TyrA 
enzymes are highly regulated by L-Tyr.  Such is the case for both the dehydrogenase and 
mutase activities of E. coli CM-PD, as well as A. aeolicus PD, which are feedback 
inhibited by L-Tyr. With both enzymes, this inhibition is dependent on the presence of 
NAD
+
.  Double reciprocal plots of velocity at varying prephenate concentrations and 
fixed, increasing concentrations of L-Tyr are notably concave upward, suggestive of 
cooperative interactions between subunits in the binding of L-Tyr (18, 28, 35, 41). 
Several models for E. coli CM-PD have been proposed to explain these kinetic findings. 
The results of analytical ultracentrifugation experiments with E. coli CM-PD suggest that 
the enzyme exists in active dimer and inactive tetrameric forms and that NAD
+
/L-Tyr 
shifts the equilibrium in favour of the tetramer (41). In contrast, Christopherson and 
colleagues (18), proposed that the concave upward kinetics (observed at low enzyme 
concentrations) could be due to a tertiary structural changes such that the binding of L-
Tyr to one subunit promotes the binding of a second tyrosine molecule to the other 
subunit (18, 45). In both of these models, L-Tyr was presumed to bind at the active site. 
Turnbull and colleagues (29) proposed an alternate mechanism based on the results of 
fitting initial velocity data to several models and by analyzing the patterns of inhibition in 
the presence of both HPP and L-Tyr. They hypothesized that tertiary structural changes 
that occur upon L-Tyr binding occurs by L-Tyr’s interaction at an allosteric site, since L-
18 
 
arogenate (which also possesses  a side chain amino group) is a poor substrate for the PD 
reaction; the L-Tyr-enzyme-prephenate complex remains active although markedly less 
so than the enzyme-prephenate complex. Interestingly, neither A. aeolicus PD or H. 
influenzae Δ80 CM-PD undergo tetramerization in the presence of L-Tyr, thus favouring 
a model of tertiary structural changes (22, 49). Additionally, crystal structures of these 
two enzymes in complex with NAD
+
 plus L-Tyr show the end product bound at the 
active site (31,40, 47), which argues against the presence of an allosteric site for L-Tyr to 
bind.  
 
1.8 Arogenate Dehydrogenase from Synechocystis sp. PCC 6083 
Synechocystis sp. PCC6803 is a freshwater cyanobacterium, and is one of the most 
highly studied in its class. It is an autotroph when in the presence of sunlight and a 
heterotroph when sunlight is absent. The arogenate (formerly called pretyrosine) pathway 
was first discovered by Stenmark and colleagues (57) in cyanobacteria. As no PD activity 
could be detected in this organism, they proposed that L-Tyr biosynthesis must proceed 
via an alternate intermediate. It was not until 2004 that a putative tyrA gene encoding a 
monofunctional AD was identified from the sequenced genome of Synechocystis sp, 
recombinantly expressed in E. coli and purified (15). The enzyme consists of 279 amino 
acids with a predicted molecular weight of 30.2 kDa per monomer. The molecular weight 
of the native wild-type enzyme has been reported in the range of 57 – 65 kDa, confirming 
that AD is a dimer in solution (15). The NADP
+
-bound crystal structure was determined 
in 2006 (48), and it currently remains the only AD for which there is a crystal structure. 
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Bonner and colleagues (15) and Legrand and colleagues (48) have conducted kinetic 
studies on recombinant AD from Synechocystis sp.  Both groups have shown that this 
enzyme displays an absolute specificity for NADP
+
 and L-arogenate (15, 48), although 
other results are not in agreement. Legrand et al. reported that the enzyme exhibited a 
rapid equilibrium random kinetic mechanism, mirroring the findings for the E. coli PD-
catalyzed reaction (83).  In contrast, the finding of Bonner et al. from dead-end inhibition 
studies in the presence of a nucleotide analog 2’,5’-ADP indicated that the enzyme 
followed a preferred ordered kinetic mechanism with L-arogenate combining with the 
free enzyme prior to the co-factor (15). Furthermore, Bonner et al showed that L-Tyr was 
a competitive inhibitor with respect to L-arogenate, while Legrand et al reported that the 
same enzyme was insensitive to inhibition by the end product of the reaction. The latter 
group proposed that this discrepancy could be due to amino acid replacements (H264Q, 
R265H, L266R, and Q268L) present in the C-terminal domain in the enzyme studied by 
Bonner and colleagues. This discrepancy is under investigation in the present study. 
Legrand and colleagues also proposed that the active site residues H179, G219, G221, 
G226, M228, and Tyr232 might help define the enzyme’s strict preference for L-
arogenate, although there have been no mutagenesis studies reported to test this 
hypothesis. These residues were selected after positioning L-arogenate in the active site 
of the NADP
+
-bound structure (Figure 8C).  This was done by placing the C4 hydroxyl 
group of L-arogenate on top of a water molecule located 2.5 Å from H112, presumed to 
be the reaction’s catalytic hydrogen bond acceptor (H197 in E. coli CM-PD and H147 in 
A. aeolicus ∆19PD). L-arogenate’s C-4 hydrogen atom was close enough (2.6 Å) to the 
C-4 atom of the oxidized nicotinamide so that hydride transfer could occur. Of the 
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residues identified by Legrand and colleagues, only H179 is highly conserved. G221 was 
speculated to be particularly important for determining L-arogenate selectively; the small 
side chain was argued to be important for accommodating the larger, charged nitrogen 
atom of L-arogenate’s side chain (48). Legrand also speculated that a group of aliphatic 
side-chains (V182, V218, L225, M228, and M229) comprises a hydrophobic pocket 
which was predicted by Hermes and colleagues (38) to promote a concerted reaction 
mechanism. The reaction’s dienone intermediate becomes so short-lived that C-C 
cleavage occurs in the same transition state as hydride transfer (38). In Legrand’s model 
(Figure 8), the side chains of these groups are pointing towards the ring carboxyl group of 
arogenate, supporting this theory. R217 in AD from Synechocystis sp (R294 and R250 in 
E. coli CM-PD and A. aeolicus Δ19PD, respectively) is located on an ɑ-helix in a very 
polar, solvent-exposed environment and too far away from the active site to interact with 
L-arogenate. This prompted Legrand and colleagues to suggest that this cationic residue 
was not important for substrate binding in TyrA proteins (48), despite kinetic results on 




Figure 8: Selected active site residues of Synechocystis sp AD complexed with NADP
+
 
at pH 8.0 with arogenate placed in the active site. The overall tertiary structure of the 
monomer of Synechocystis sp AD (A) shows the location of the active site, with L-
arogenate in cyan. A close-up view of the active site (B) shows residues that are closest to 
arogenate. Arogenate was placed into the active site similarly to Legrand and colleagues 
(48) so that the C4 hydroxyl group is close enough to H112 to hydrogen bond, and the C4 
ring hydrogen is close enough to the oxidized C4 nicotinamide ring of NADP
+
 for hydride 
transfer to occur. R213 and R217 are 9.8 Å and 15.1 Å away from the closest atom of 
arogenate when in this position, respectively. Legrand and colleagues’ arogenate 
placement (C) shows the hydrophobic pocket partially facing the ring carboxyl group of L-
arogenate. This was observed as well in (B), but the residues are not shown for clarity. See 
“Discussion” for further analysis.
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Interestingly, this arginine is absent in plant ADs, such as that from Arabidopsis 
thaliana. Another residue in the Synechocystis sp AD, R213 (equivalent K246’ in A. 
aeolicus Δ19PD), is located on the same helix as R217, but even more distant from the 
active site and closer to the C-terminal dimerization domain.  
No mutagenesis studies have been performed on any AD TyrA proteins to date.  
Accordingly, the above mentioned residues in Synechocystis sp AD and a number of 
others have been examined in this thesis, and their importance in the enzyme’s catalytic 
mechanism will be addressed.  
 
1.9 Synthesis and Purification of Arogenate 
The substrate for AD, L-arogenate, is not commercially available, hence a number of 
different protocols have been developed in order to obtain the compound. Jensen and 
colleagues (50) first reported the isolation of arogenate from an auxotroph of N. crassa 
that carries multiple metabolic blocks in the aromatic amino acid biosynthetic pathway 
(Figure 8, left hand panel), thus favouring the accumulation of L-arogenate.  L-arogenate 
was enriched from the accumulation media by barium precipitation and Dowex-chloride-
21K-anion exchange chromatography. Using the same strain, Zamir and colleagues (15) 
modified the procedure to include two more chromatography steps (AG1-X8-Cl anion 
exchange and Sephadex G-10 size exclusion) and reported a purity of 95% as assessed by 
1
H-NMR. Bonner and colleagues (52) continued to use the protocol of Zamir and 
colleagues, but replaced the N. crassa strain with a metabolically blocked mutant of 
Salmonella typhimurium (Figure 8, right panel) in an attempt to increase the yield of L-
arogenate. They reported as much as 30% of the total cyclohexadienyl accumulation in 
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the culture supernatant can be L-arogenate from the tyrA19 mutant, although the isolation 
procedure is very lengthy. 
Zamir and Jensen (53) were also the first to use HPLC in order to quantify L-
arogenate and to follow its enzymatic conversion by AD. Prior to HPLC analysis, 
reaction mixtures were derivatized with o-phthalaldehyde (OPA) – a reagent that reacts 
covalently with primary amino groups of amino acids (such as L-arogenate, L-Tyr) to 
yield compounds that can be detected flurometrically at 455 nm when λex = 360 nm. This 
method remains a useful way to verify enzyme activity, particularly for enzymes whose 
substrates or products do not exhibit a unique spectrophotometric or flurometric  
 
Figure 9: The pathways of tyrosine and phenylalanine biosynthesis in N. crassa, S. typhimurium, and 
S. typhimurium tyrA19 mutant. In N. crassa (left), prephenate dehydrogenase (1) and prephenate 
dehydratase (2) transform prephenate (PPA) into HPP and phenylpyruvate (PPY), respectively. Prephenate 
can also be transaminated to arogenate (AGN) by prephenate aminotransferase (3). The mutant used for 
arogenate accumulation possesses deficiencies in enzymes (1) and (2), favouring arogenate production. The 
hollow arrows represent enzymatic reactions that exist in other organisms, but are not present in N. crassa. 
In wild type S. typhimurium (center), chorismate (CHA) becomes prephenate (PPA) by enzymes (1), (2), or 
(3). These enzymes correspond to monofunctional chorimsate mutase enzymes, which are along the 
pathway for the synthesis of L-Tyr, L-Phe and L-Tyr (through L-arogenate), respectively. Prephenate will 
be directed to the synthesis of tyrosine through enzyme activity (4), prephenate dehydrogenase or to 
phenylalanine through enzyme activity (5), prephenate dehydratase. In the tyrA19 mutant (right), 
cyclohexadienyl dehydrogenase activity (4) has been removed and (2) and (5) (chorismate mutase and 
prephenate dehydratase, respectively) are sensitive to phenylalanine feedback inhibition. As such, 
arogenate production is favoured. 
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signal. The activity of prephenate aminotransferase, which transaminates prephenate to 
L-arogenate, was also assayed in this manner (54). Due to the covalent modification by 
OPA, however, the resulting derivatized arogenate is not suitable for use in kinetic 
studies. 
In 1983, Danishefsky and colleagues (55) reported the total synthesis of L-arogenate 
from pyroglutamate.  The identity of the final product was confirmed by
1
H NMR analysis 
but the poor yield and multi-step synthesis rendered this protocol impractical for 
sustaining moderate quantities of L-arogenate for enzymatic and biophysical studies on 
AD.   
Most recently, Rippert and colleagues (56) reported the enzymatic synthesis of L-
arogenate enzymatically by the transamination of prephenate via prephenate 
aminotransferase (PAT). For this purpose, these authors obtained a crude preparation of 
PAT by harvesting and grinding the leaves of Nicotiana tabacum.  Fortunately, the genes 
encoding PAT from Petunina hybrid and Arabidopsis thaliana have very recently been 
reported (54). As will be outlined in this thesis, purified recombinant PAT can now be 
used to synthesize L-arogenate from prephenate. 
 
1.10 Research Objectives 
The overall goals of this study were two-fold: 1) to commence the first mutagenesis 
study on AD, targeting those residues which may play a role in substrate binding, 
catalysis and end product inhibition; 2) to develop a procedure in order to obtain L-




In our first goal, both the crystal structure of Synechocystis sp AD and multiple amino 
acid sequence alignments revealed a number of residues in the active site that could 
potentially play a role in arogenate specificity, substrate binding and/or catalysis. As 
previously discussed, H112 is expected to be the catalytic hydrogen bond acceptor in the 
reaction; as there are no mutagenesis studies reported for this TyrA protein, this residue 
was changed to alanine to note the effects on enzyme activity.  G221 was speculated by 
Legrand and colleagues (48) to be critical for arogenate selectivity. Thus, G221 was 
replaced with serine and glutamine, the equivalent residues in the A. aeolicus PD and E. 
coli CM-PD, respectively, to note any effects on substrate preference. Both S178 and 
H179 are conserved in many TyrA proteins, although they are replaced by glutamine and 
alanine in other members of the family. Furthermore, the equivalent residues in A. 
aeolicus PD were shown to play a role in prephenate binding (42).  Accordingly, both 
single and double variants, S178A, H179A, and S178Q/H179A were constructed to probe 
the effects on AD activity. M228 was speculated to be important for AD catalysis, as it 
was hypothesized to help define a hydrophobic pocket within the active site which might 
be critical for product release (38, 48). Accordingly, this residue was replaced with the 
hydrophilic amino acid aspartic acid that might disrupt this hydrophobic pocket, and 
perturb enzyme activity. G226 was another residue speculated by Legrand and colleagues 
to play a role in arogenate specificity. Furthermore, equivalent residues in E. coli CM-PD 
and A. aeolicus PD, Y303 and W259, respectively were found to play an important role 
in L-Tyr binding and inhibition. As such, G226 was replaced with tyrosine to note the 
effect on enzyme activity, particularly in the presence of the end product. Despite the fact 
that the crystal structure of AD in complex with NADP
+
 revealed that R213 and R217 
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are too far away from the active site to interact directly with L-arogenate, these two 
residues were replaced with alanine to probe their importance in enzyme function; the 
equivalent residues in other TyrA proteins were found to be important in binding 
prephenate (37, 42). The highly conserved D171 and H170 were targeted for 
mutagenesis and replaced with alanine and asparagines, respectively; in particular, 
D171s’ homolog in A. aeolicus Δ19PD was found to be critical for enzyme function and 
stability (42). Lastly, the importance of C-terminal residues H264, R265 and L266 in 
conferring end product inhibition were probed by characterizing the single variant 
H264Q as well as triple variants derived combinatorially with R265H and L266R. These 
studies targeted three of the four amino acid replacements which might have lead to a 
discrepancy in the results reported by Bonner et al(15) and Legrand et al (48) with regard 
to L-Tyr sensitivity.    
In total, fifteen Synechocystis sp AD variants were generated by site-directed 
mutagenesis, expressed in E. coli and purified to homogeneity using Reactive Red120 
Agarose affinity chromatography.  Their specific activities were determined 
spectrophometrically and the values compared to the wild-type enzyme. Circular 
dichroism (CD) was used to confirm that secondary structure of the variants was not 
disrupted, and to determine the thermal stabilities of selected enzymes. The effects of 
amino acid substitutions on tertiary structure of AD were assessed using fluorescence 
emission spectroscopy. Additionally, the binding of NADP
+
 to the wild-type enzyme was 
also investigated by recording changes in fluorescence emission. Where applicable, 
molecular modelling was used to help explain the effects produced by the amino acid 
replacements.   
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Addressing our second goal, we chose to obtain L-arogenate using a protocol adapted 
from Rippert and colleagues (56).  This method involves the enzymatic conversion of 
prephenate to L-arogenate via prephenate aminotransferase, which is then linked to a 
coupled enzyme reaction that can be monitored spectrophotometrically. Prephenate was 
readily available in our laboratory and we had recently obtained access to the clone 
encoding PAT from Petunia hybrida. Next, purification of L-arogenate using HPLC was 
developed on the analytical scale and adapted to the preparative scale. Identities of the 


















Chapter 2: Materials and Methods 
2.1 Materials 
Chorismate (free acid form) was isolated and purified from Klebsiella 
pneumonias (60). Prephenate (barium salt) was prepared enzymatically from chorismate 
as previously described (61). Crude L-arogenate (purity ~4%) used in specific activity 
measurements was a kind gift from Carol Bonner. L-arogenate was prepared 
enzymatically from prephenate as described in section 2.9. NAD
+
 (grade I) was obtained 
from Roche while NADP
+
 (grade I) was obtained from Sigma Aldrich. Stock solutions of 
substrates were prepared in the appropriate buffers and stored at –20ºC in small aliquots. 





) or enzymatic end-point analysis (arogenate, prephenate and chorismate) 
(62, 63). L-Tyr and L-Phe were purchased from ICN Biochemicals Inc. Ampicillin 
(sodium salt), kanamycin sulphate, chloramphenicol, IPTG, phenyl-methyl-sulfonyl 
fluoride (PMSF, prepared to 0.5M stock solutions in methanol and stored at –20ºC) and 
dithiothreitol were obtained from BioShop. Oligonucleotides of standard purity were 
ordered from BioCorp (Montréal, QC). GeneJET
TM
 Plasmid Miniprep Kit was purchased 
from Fermentas Life Sciences, while PureLink
TM
 Quick Gel Extraction Kit was 
purchased from Invitrogen. Restriction enzymes DpnI, NdeI, BamHI, XhoI, NcoI, (all at 
10 U/μL), and the deoxy-NTP (dNTP) mixture (5 mM of each dNTP, stored at -20ºC in 
small aliquots) were purchased from MBI Fermentas. Phusion® High-Fidelity DNA 
Polymerase (2.0 U/μL) was purchased from New England Biolabs Inc. Benzonase 
Nuclease was obtained from Novagen. Complete
TM
, Mini, EDTA-free protease inhibitor 
cocktail tablets were purchased from Roche. Amersham Biosciences supplied thrombin 
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protease (purified from bovine plasma, 500 U resuspended in 500 μL of phosphate 
buffered saline) and NAP
TM
-5 size exclusion buffer exchange columns pre-packed with 
DNA grade Sephadex
TM
 G-25, while Ni-NTA Superflow
TM
 chromatography resin was 
purchased from Qiagen. Reactive Red Agarose 120 affinity chromatography resin was 
supplied by Sigma. Dialysis membrane (MW cut-off 12-14 kDa) from Spectrapor was 
washed according to manufacturer’s instructions. All other chemical reagents and 
solvents were purchased commercially and were of the highest quality available. 
 
2.2 Strains and Plasmids 
The E. coli strain XL10-Gold ultracompetent (Stratagene) Tetr
rΔ(mcrA)183 
Δ(marCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F’proAB 
lacI
q





 Hte ompT hsdS(rB
-
 mB
-) gal λ (DE3) endA Tetr] was used for 
protein expression. The cells were either purchased commercially ready to use or 
rendered competent using calcium chloride (20). Recombinant wild-type AD plasmid 
was previously constructed by Dr. P. Hanic-Joyce by cloning Synechocystis sp. PCC 
6803 tyrAa encoding amino acid residues 1-279 of AD into the XhoI and NdeI restriction 
sites of E. coli expression vector pET24a (Novagen), yielding pET24a-tyrAa. The 
construct, pET28a-PAT, which contains the truncated Petunia hybrida PhPPA-AT gene 
cloned into the NdeI and BamHI sites, encodes amino acid residues 59-479 of PAT and 






2.3. Bacterial Growth Media  
Luria-Bertani (LB) medium was prepared with 1% tryptone, 0.5% yeast extract 
and 1% NaCl in distilled H2O (pH was adjusted to 7.5) while LB agar was prepared with 
1.5% agar in LB medium. Both media were sterilized by autoclaving at 121ºC. Stock 
solutions of ampicillin (100 mg/mL), and kanamycin (10 mg/mL) were prepared in 
MilliQ-H2O, and chloramphenicol (30 mg/mL) in ethanol, and were filter sterilized by 
passage through a 0.45 μm syringe (VWR) and stored at -20°C.  
 
2.4. Site-Directed Mutagenesis  
Oligonucleotides used for the mutagenesis reactions (see Table 1) were 
resuspended in MilliQ-H2O and their concentrations were determined by measuring using 
an Implen Nanophotometer located in the Center for Structural and Functional Genomics 
(Concordia University). The plasmid pET24a-TyrAa and was used as template plasmid 
for site-directed mutagenesis. The plasmid was isolated from a 5 mL culture of E. coli 
XL-10-Gold ultracompetent cells harbouring the plasmid using the GeneJET
TM
 Plasmid 
Miniprep Kit (Fermentas Life Sciences), and its concentration was determined using the 
Nanophotometer.  
Site-directed mutagenesis was conducted according to the instructions supplied in 
the QuickChange
TM
 XL Site-Directed Mutagenesis Kit. The reaction mixtures were 
prepared with 15 ng of double stranded (ds) DNA template, 125 ng of each 
oligonucleotide primer (forward and reverse), 0.5 μL of Phusion® High-Fidelity DNA 
polymerase (2 U/μL), 10 μL of 5 x Phusion® HF buffer, 1 μL of a 5 mM dNTP solution. 
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Reaction mixtures for the R217A and S178A also contained 10% DMSO due to the high 
G/C content of their primers. DNA polymerase was added just prior to the first 
denaturation cycle. PCR amplification was carried out using a GeneAmp PCR system 
9700 (Applied Biosystems). The temperature cycle parameters are listed in Table 2. 
Briefly, double-stranded plasmid DNA was denatured at 98˚C then oligonucleotide 
primers were annealed to the plasmid at 60 ºC. Synthesis and extension of the new DNA 
strand was catalyzed by the DNA polymerase at 72˚C. Reaction mixtures were stored at 
4˚C in the apparatus until processed further. 
Table 1: Primer sequences for site-directed mutagenesis of Synechocystis AD 
AD Variants Oligonucleotide Primer Sequence 
SH178QA 5’ CCAAGCAGTAGCCTGGATTCAGGCTTTACCTGTAATGGTGAGTGC 3’ 
G221Q 5’ GATACCAGTCGGGTGGGAGGCCAAAACCCGGAGTTGGGCACCATG 3’ 




M228D 5’ GCAACCCGGAGTTGGGCACCGACATGGCCACCTATAACCAACG 3’ 
G226Y 5’ GAGGCGGCAACCCGGAGTTGTACACCATGATGGCCACCTATAAC 3’ 
G221S 5’ GATACCAGTCGGGTGGGAGGCAGCAACCCGGAGTTGGGCACCATG 3’ 
T117P 5’ GGTCACCCCATGGCCGGCCCAGCGGCCCAGGGCATCG 3’ 
R217A 5’ GGTTTTCGGGATACCAGTGCGGTGGGAGGCGGCAACCCGG 3’ 
R213A 5’ GGCCAGTTCGGGTTTTGCGGATACCAGTCGGGTGGG 3’ 
S178A 5’ CCAAGCAGTAGCCTGGATTGCCCATTTACCTGTAATGGTG 3’ 
D171A 5’ GCACTCCCGCAGACCATGCCCAAGCAGTAGCCTGG 3’ 
H112A 5’ GGGTTCATTGGTGGTGCCCCCATGGCCGGCACAG 3’ 
H170N 5’CACTCCCGCAGACAATGACCAAGCAG 3’ 
H179A 5’ CAGTAGCCTGGATTTCCGCTTTACCTGTAATGGTG 3’ 
Primers were designed considering length, GC content and location, and melting temperature 
using Primer3 Output program (http://frodo.wi.mit.edu/primer3/input.htm) (64)). Bold and 
underlined letters represent bases that differed from the wild-type sequence. Complementary 










Table 2: Temperature cycling parameters for PCR using Phusion 
®
 HF DNA Polymerase 
Number of Cycles Temperature (°C) Time (s) 
1 Denaturation 98 120 
 
18 
Denaturation 98 60 
Annealing 60 60 
Extension 72 300 
1 Extension 72 600 
 Cooling 4  ∞ 
 
 Upon completion of the temperature cycling, methylated and hemi-methylated 
parental DNA were digested by incubation of the reaction mixtures with DpnI restriction 
endonuclease (10 U) at 37°C for 3 h. The presence of amplified DNA was confirmed by 
electrophoresis on a 0.7% agarose gel (see section 2.6) and transformed into E. coli stain 
XL10-Gold ultracompetent cells (see section 2.5). All cells were then plated on LB/agar 
containing kanamycin (50 μg/mL). After overnight incubation at 37ºC, single colonies 
were selected and inoculated separately into 10 mL of liquid LB medium containing 
kanamycin (50 μg/mL) and grown overnight at 37ºC with shaking at 225 rpm. The 
plasmid DNA was extracted and purified using the GeneJET
TM
 Plasmid Miniprep Kit 
(Fermentas). The protocol was modified by eluting the DNA using MilliQ-H2O instead of 
the buffer provided in the kit. The concentration and purity of the plasmid DNA were 
determined using an Implen Nanophotometer.  
Aliquots of purified plasmid DNA were sent for sequencing of the tyrAa gene 
(McGill University and Génome Québec Innovation Centre). The resulting sequences 
were aligned with that of WT tyrAa, using the BLAST tool on NCBI 
(http://www.ncbi.nlm.nih.gov/blast) to ensure that the desired mutation was achieved and 




2.5  Transformation 
DpnI-treated PCR products were transformed using a rapid transformation 
protocol described by Sambrook and Russell (65). Briefly, purified DpnI-treated PCR 
products (10 μL) were added to 50 μL of XL10-Gold ultracompetent cells, mixed and 
incubated on ice for 15 min. The cells were then incubated at 42ºC for 45 s (heat-shock) 
and subsequently kept on ice for 5 min. One mL of LB broth (section 2.3) was added to 
the reaction, and the cells were incubated for 1 h at 37°C, with shaking at 225 rpm. The 
transformed cells were centrifuged at 5000 rpm for 10 min (Eppendorf Centrifuge 5415 
C), and excess LB broth was removed. The transformed cells were then plated on 
LB/agar containing 50 μg/mL kanamycin and grown for 16 h at 37ºC.  
Transformation for AD protein expression was performed using the same method 
as described above. Briefly, ~ 200 ng AD plasmid DNA was mixed with 50 μL of 
BL21(DE3) competent cells, placed on ice for 15 min followed by heat-shock for 45 s at 
42ºC and then incubated on ice for 5 min. The entire mixture was plated on LB/agar 
containing 50 μg/mL kanamycin and incubated for 16 h at 37ºC. 
 
2.6 Agarose Gel Electrophoresis  
Agarose gel electrophoresis (0.7% agarose) was used to verify the amplification 
of plasmid DNA and PCR products. Agarose (0.35 g) was dissolved in 50 mL TBE 
buffer (45 mM Tris-borate/1 mM EDTA, pH ~ 8.3) and heated for 2 min in a microwave. 
After the agarose solution had cooled to 55ºC, ethidium bromide (0.5 μg/mL) was added. 
DNA samples and molecular weight markers (Gene Ruler 1kbp DNA ladder, Fermentas) 
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were mixed with 6 x loading dye (Fermentas). Electrophoresis was performed at 100V 
until the loading dye migrated to the middle of the gel. DNA was visualized using a 
FluoroChem FC2 Imaging Illuminator. 
 
2.7 Expression and Purification of AD Proteins 
 AD and variants were purified by the method of Legrand and colleagues
 
(48) with 
minor modifications. Single colonies were selected from freshly plated transformants of 
E. coli BL21(DE3) cells containing plamids of wild-type or mutant TyrAa, and a 10 mL 
culture (LB medium containing 50 μg/mL of kanamyacin) was grown overnight at 37°C 
with shaking (225 rpm). Five mL of this culture were then diluted into each of 2 x 1.5 L 
of the same medium. These cultures were grown at 37°C with shaking until they reached 
an OD600 of 0.6-0.8 (after about 3 h). Protein expression was then induced by adding 0.4 
mM IPTG and the cultures grown for an additional 3 h at 37°C. The cultures were then 
centrifuged at 5,000 rpm (Beckman centrifuge J2-HS, JA-10 rotor) at 4°C for 15 min, and 
the supernatant discarded. The pellet was stored at -80°C overnight, and then placed at      
-20°C until use. All steps of the purification were performed at 4°C. 
 The pellet was thawed and then resuspended into buffer A (50 mM Tris-HCl, 1 
mM EDTA, 1 mM DTT, pH 7.5) using 5 mL/g of wet cell pellet. Buffer A was 
supplemented with Complete
TM
 protease inhibitor cocktail tablet (one tablet/50 mL of 
resuspension buffer). The mixture was homogenized using a Dounce Homogenizer (at 
least 5 up-and-down strokes), and the cell walls were disrupted by two passages through 
a French pressure cell with a setting of 1000 psi. The cell lysate was then centrifuged to 
clarity using a Beckman centrifuge for 1 h at 20,000 rpm (JA-20 rotor, Beckman) at 4°C. 
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A 50 μL aliquot of the supernatant was removed and stored for SDS-PAGE analysis. The 
cell-free extract was dialysed in 4 L of buffer A overnight at 4°C.  
The dialysed extract was then applied to Reactive Red Agarose 120 resin (25 mL 
bed volume) in a 2.6 x 5 cm glass column conditioned previously with ice-cold buffer A 
at 1 mL/min. After the flow-through was collected, the resin was washed at a flow rate of 
3 mL/min with approximately 150 mL of buffer A. The protein was eluted with a 100 mL 
linear gradient of buffer A containing 0-2 M NaCl. Fractions (about 5 mL) were 
examined at 280 nm to estimate protein concentration and the flow-through, wash, and 
elution contents were examined by SDS-PAGE. Fractions containing AD (electrophoretic 
band at 30 kDa) were then pooled and dialysed in 4 L of buffer A overnight at 4°C. 
Aliquots of protein (1 mL) were stored in buffer A containing 50% glycerol at -20°C. 
 
2.8 Expression and Purification of Prephenate Aminotransferase 
 PAT protein were expressed, and cell-free extracts harbouring recombinant 
proteins were prepared as described for AD and its variants (section 2.7) with the 
exception that the cells were resuspended in buffer B (50 mM Tris-HCl, 100 mM NaCl, 
10% glycerol) prior to lysis. The cell-free extract was applied to a 10 ml Ni-NTA 
Superflow column (binding capacity: 5-10 mg of His-tagged protein per mL resin), 
previously equilibrated with ice-cold buffer B containing 5 mM imidazole using a flow-
rate of 1 mL/min. After the flow-through was collected, the column was washed at a 
flow-rate of 3 mL/min with 300 mL of buffer A supplemented with 30 mM imidazole. 
Bound His-tagged protein was eluted with buffer A containing 300 mM imidazole and 
1.5 mL fractions supplemented with 1 mM EDTA were collected during elution. Protein 
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elution was monitored quantitatively by adding 10 μL of every third fraction collected to 
990 μL Bio-Rad Bradford dye and recording the absorbance at 595 nm. Those fractions 
with the highest protein content and were pooled and dialyzed (Spectrapore, 12kDa cut-
off) overnight at 4ºC against buffer B containing 2.5 mM CaCl2. Protein was 
concentrated, if necessary, to 2-10 mg/mL (Amicon Ultra-15, MW cut-off 10 kDa) and 
stored at -20ºC in buffer B supplemented with 50% glycerol. Each step of the purification 
procedure was monitored by SDS-PAGE (12% acrylamide). Protein concentration was 
determined using the Biorad protein assay (see section 2.12). 
 
2.9 Arogenate Synthesis 
L-arogenate was synthesized enzymatically using a coupled assay adapted from 
Rippert et al. (56) with purified PAT (section 2.8) and malate dehydrogenase (MDH, EC 
1.1.1.37, Sigma). In the presence of pyridoxal-5-phosphate, PAT produces arogenate 
from prephenate and an amino donor, which can be either L-aspartate or L-glutamate. 
The reaction catalyzed by PAT was enzymatically coupled to MDH since neither the 
appearance of L-arogenate nor the disappearance of prephenate or L-aspartate can be 
easily monitored spectrophotometically or flurometrically. Reactions were carried out in 
20 mM sodium phosphate buffer (pH 8.0) at 37°C in the presence of 5.4 mM barium 
prephenate, 10 mM L-aspartate, 16.2 mM NADH, 50 μM PLP, 10 μg of PAT, and 44 
units of MDH in a final volume of 1 mL. The reaction was monitored by removing 5 μL 
aliquots of the reaction mixture at numerous time intervals, diluting it into 995 μL of 50 
mM NaOH, and recording the absorbance at 340 nm. Once the absorbance had decreased 
to a value corresponding to the conversion of prephenate to L-arogenate (ΔA340 = 0.22), 
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the reaction was stopped by flash-freezing in liquid nitrogen. The reaction vials were kept 
at -80°C until further use. 
 
2.10 High Pressure Liquid Chromatography and Liquid Chromatography-Mass 
Spectrometry 
 High pressure liquid chromatography (HPLC) was performed both on the 
analytical and preparative scales at ambient temperature. For analytical analysis, samples 
prepared in section 2.9 were centrifuged for 10 min at 13,000 x g in order to remove any 
precipitated protein debris. An Agilent HPLC system was used equipped with a C18 
column (5 um, 150 mm x 4.6 mm). A 15 min linear gradient from 1 to 30 % acetonitrile 
in 20 mM sodium phosphate buffer (pH 7.6). Arogenate, NAD
+
, and NADH peaks were 
monitored at 210 nm and quantified based on a standard calibration curve generated with 
individual standards, when available. Peak identities were further confirmed by liquid 
chromatography-mass spectrometry (LC-MS) using a Quattro-LC mass spectrometer 
(Waters micromass) equipped with an Agilent HPLC system. The analytical HPLC 
method was adapted to a preparative scale using a XBridge C18 column (5 um, 100 x 10 
mm, Waters) and a Agilent HPLC system with fraction collector, kindly provided by Dr. 
Pat Forgione (further experimental details are described in Results). 
 
2.11 Determination of Protein Concentration 
Concentrations of protein purified to near homogeneity (>95% homogenous) were 




 for all AD proteins (with 
the exception of G226Y) and measuring the OD280. Extinction coefficients were 
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determined experimentally using the Edelhoch method (66) in duplicate. Identical 
dilutions of protein were made into 30 mM MOPS, 1 mM DTT buffer, pH 7.0, and into 
the same buffer containing 6 M GdnHCl. UV spectra were measured between 250-350 
nm with buffer alone and with protein. The extinction coefficient of the protein in 6 M 
GdnHCl was calculated using determined extinction coefficients for tryptophan, tyrosine 
and cystine in 6 M GdnHCl: 
(6MG) = (#Trp) ελ(Trp,6MG)+(#Tyr) ελ(Tyr,6MG)+(#cystine) ελ(cystine,6MG) 
(6MG) = (3Trp)5,685(Trp,6MG)+(7Tyr)1,285(Tyr,6MG)+(0cystine) 125(cystine,6MG) 
From this, the protein concentration in 6 M GdnHCl is calculated, which is equal to the 
concentration of protein in the buffer. With this, the extinction coefficient of the protein 
is calculated using: 
ε280(buffer) = A280(buffer)/C(buffer) 









, respectively. When compared to the theoretical 









calculated using the ExPasy ProtParam server, the differences between the experimental 
and theoretical coefficients were found to be 4.6% and 2.1%, respectively. 
 Protein concentration of crude extracts and prephenate aminotransferase was 
calculated using the Bio-Rad protein assay kit (Bio-Rad Laboratory) with bovine serum 
albumin (BSA, Sigma) as a standard. (85) BSA was dissolved in 10 mM Tris-HCl, pH 
7.4, filtered using a 0.2 μm syringe and its concentration was determined by OD280 




2.12 Polyacrylamide Gel Electrophoresis 
 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
used to assess the purity and estimate the molecular weights of proteins under denaturing 
conditions. SDS-PAGE was performed using a 4% acrylamide stacking gel (pH 6.8) and 
12% acrylamide resolving gel (pH 8.3) as reported by Sambrook et al. (65). The 30% 
acrylamide stock solution was prepared by mixing 29% (w/v) acrylamide and 1% (w/v) 
N, N’-methylene-bis-acrylamide in distilled H2O. Resolving gel buffer (1.5 M Tris-HCl, 
pH 8.3) and stacking gel buffer (0.5 M Tris-HCl, pH 6.8) were prepared in distilled water 
and the pH was adjusted using HCl. The acrylamide and Tris buffer solutions were stored 
at 4ºC. Ten percent SDS (w/v) in distilled water was stored at room temperature while 
10% (w/v) ammonium persulfate prepared in distilled water was stored at -20ºC. 
Electrophoresis buffer was composed of 25 mM Tris-base, 250 mM glycine and 0.1% 
SDS, pH 8.3. Protein samples and protein molecular weight marker (Fermentas) were 
diluted 1:1 (v/v) into 2 x SDS gel-loading buffer (1.5 M Tris-HCl, 4% SDS, 20% glycerol 
(v/v), 0.002% Bromophenol Blue, pH 6.8) and denatured in boiling water for 5 min 
before loading onto the gel. Electrophoresis was conducted at 120 V and terminated when 
the Bromophenol Blue tracking dye migrated off the resolving gel. Proteins were 
visualized by first washing the gel in warm distilled water three times for 2 min, followed 
by staining in a solution of 0.1% (w/v) Brilliant Blue-G250 (BioShop) and 35 mM HCl in 
distilled water, until bands appeared (66). Contrast could be enhanced by placing the gel 





2.13 ESI-ToF Mass Spectrometry 
 The molecular weights of wild-type and variant AD proteins were confirmed 
using ESI-ToF-MS. Samples were prepared using a protocol developed by J. 
Manioudakis for E. coli CM-PD (84).  Briefly, to 100 μg of protein was added 300 μL 
methanol, 100 μL chloroform and 200 μL MilliQ water. The mixture was vortexed for 5 s 
after each solvent addition. Next, the sample was centrifuged (Eppendorf Centrifuge 
5415 C) at 16 000 x g for 3 min. The two visible liquid phases were now separated by a 
thin layer of precipitate containing the protein. After carefully removing all of the liquid, 
300 μL methanol was added to the precipitated protein, and the sample was vortexed for 
5 s and then centrifuged (16 000 x g) for 2 min. This wash step repeated once more. After 
the second wash step the methanol was decanted and the protein pellet was dried at room 
temperature in the fume hood. The dried pellet was resuspended in 300 μL of 30% 
methanol/0.2% formic acid (v/v) and then the sample was centrifuged for 5 min to 
remove all insoluble material.  The samples were applied to a Waters Micromass Q-ToF 
2 triple-quadrupole mass spectrometer by direct injection at a flow rate of 1 μL/min. 
Samples were analyzed in the positive-ion mode within an m/z range of 700-2000 using 
Mass Lynx 4.0 software (Waters Micromass). Instrument parameters were as follows: 
source block temperature: 80 °C; capillary voltage: 3.5 kV; cone voltage: 35 V; ToF: 9.1 







2.14 Determination of Enzyme Activities and Kinetic Parameters 
The oxidative decarboxylation of L-arogenate in the presence of NADP
+
 was 
monitored at 340 nm as described previously (48). The reactions (total volume 500 μL) 
were monitored continuously by using a Varian Cary 50 spectrophotometer equipped 
with a thermostated cuvette holder.  
Standard activity assays for AD proteins were measured at 25ºC in a reaction 
buffer containing 50 mM Tris-HCl, pH 7.5. Buffer was incubated in a 1 mL quartz 
cuvette of 1 cm path length at 25ºC for 2 min, while NADP
+
 and 500 μM crude L-
arogenate (purity ~4% as determined by enzyme end-point assay) was added. The 
reaction was initiated by the addition of enzyme. Components were mixed by inversion 
of the cuvette. All substrates and enzyme were kept on ice prior to their addition. 
The OD340 was recorded continuously for 1 min and reaction rates were calculated 
from the linear portion of the progress curves using the software supplied with the 
spectrophotometer. Exact concentrations of substrates are listed in figure legends in the 
Results section. Values of specific activities were calculated using the following 
equation: 
 
Specific Activity (mol/min/g) = Activity/(total amount of AD in the cuvette, g) 
Activity (umol/min) = ΔC (mol/min) x Total reaction volume (L) / (1 x 10-6) 
ΔC(mol/min) = ΔA/ (εNADH x L) 
 
2.15 Far-UV Circular Dichroism Spectroscopy 
 Far-UV CD spectra of wild-type AD and variants were obtained using a Jasco-
815 spectropolarimeter equipped with a Pelletier heating/cooling temperature control 
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system. Spectra were recorded at 20°C in a 0.2 cm path-length rectangular cell (600 μL) 
from 260 to 200 nm with the following parameters: 20 nm/min scan rate, 0.2 nm 
resolution, 0.25 sec response time, 1 nm bandwidth and a sensitivity of 100 mdeg. For 
each spectrum, five accumulations were averaged and the absorbance contribution of the 
buffer was subtracted. Protein samples were prepared fresh from a -20°C stock solution 
of enzyme stored in 50 mM Tris-HCl and 50% glycerol (v/v). Proteins were first 
exchanged into a buffer containing 50 mM KH2PO4 / K2HPO4, pH 7.5 (buffer P) by 
overnight dialysis. Protein concentrations were then adjusted to ~ 5 μM monomer in the 
same buffer. Buffers were filtered (Millipore, 0.22μm) and their pH corrected. 
For variable temperature experiments, changes in ellipticity at 222 nm (1 nm 
bandwidth) were recorded from 25°C to 95°C by using instrument’s software controlled 
temperature ramping program. The following parameters were used: ΔT of 20°C/h, a 
0.2°C step resolution, and a 0.25 s response time. The protein samples were prepared 
according as described above. Spectral scans from 200-260 nm were recorded for each 
sample at the beginning and the end of each the variable temperature experiments. 
 
2.16 Near-UV Circular Dichroism Spectroscopy 
 Near-UV CD spectra of wild-type AD and variants were obtained using a Jasco-
715 spectropolarimeter. Spectra were recorded at 20°C in a 1 cm path-length rectangular 
cell (3 mL) from 320 to 250 nm with the following parameters: 20 nm/min scan rate, 0.2 
nm resolution, 0.25 sec response time, 1 nm bandwidth and a sensitivity of 100 mdeg. 
For each spectrum, ten accumulations were averaged and the absorbance contribution of 
the buffer was subtracted. Protein samples were prepared in the same manner as 
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described for far-UV CD (section 2.15). To determine any changes in aromatic CD signal 
in the presence of ligands, stock solutions of NADP
+
 (29.6 mM) and crude L-arogenate 
(44 mM) were prepared in 10 mM Tris buffer, pH 7.5, and titrated directly into the 
reaction cuvette. 
 
2.17 Fluorescence Emission Spectroscopy 
 Fluorescence spectra for wild-type AD and each protein variant were recorded at 
20°C using a Varian Cary Eclipse spectrofluorimeter equipped with Scan Software 
version 1.1. Protein samples were prepared as described in 2.13 using a monomer 
concentration of 5 μM. Excitation wavelengths of 280 for tryptophan and tyrosine 
emission and 295 nm for tryptophan emission were used. Fluorescence emission was 
scanned from 300 to 400 nm in 2 nm increments at a fast scan speed (1200 nm/min) with 
the PMT voltage set at 700 V. Both excitation and emission slit widths were set at 5 nm. 
The average of 20 scans was used to obtain the final spectrum which was then processed 
by Savitzky-Golay smoothing with a filter size of 5. A Varian 400 μL fluorescence micro 
cell (1 cm x 1cm) was used throughout all experiments. Data were exported in ASCII 
(.csv) format and spectra were constructed in Windows Word Excel 2010. All spectra 
were corrected for buffer contributions, changes in volume, and corrected for the inner 
filter effect using the following equation:  
Fcorr = Fobs antilog [(Aex + Aem) / 2] 
Where Fobs and Fcorr represent the observed fluorescence intensities and those corrected 
for the inner filter effect respectively. Absorbance readings (A) were determined at both 
the excitation (ex) and emission (em) wavelengths. Experiments involving titration of the 
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wild-type AD with ligands were set up as described in 2.16. The apparent dissociation 
constant was determined by fitting the change in fluorescence intensity at a selected 
wavelength to the Michaelis-Menthen equation using Grafit Software version 5.0 
(Erathicus Software).  
 
2.18 Molecular Modeling and Docking 
Molecular modelling was used to dock the substrate prephenate into a homology 
model for Synechocystis sp AD. First, the homology model of AD was generated using A. 
aeolicus Δ19PD as the template. The PDB file “3GGG” (A. aeolicus Δ19PD bound with 
NAD
+
 and L-Tyr) was prepared by removing all atoms and heteroatoms attributed to 
chains A and C and D using WordPad. Therefore only chain B was used for computing 
the model but additionally all heteroatoms forming tyrosine and all water molecules in 
chain B were removed. Next, a PIR file containing sequence alignment information of 
AD and Δ19PD was prepared using Notepad. MODELLER 9v8 software was used to 
generate 10 homology models using the default script, model-default.py. After evaluating 
the DOPE scores of the 10 models and aligning each onto the backbone of AD, it was 
determined that all of the models were reproducible. L-arogenate was then docked into 
the homology model using Autodock Vina (75). First, a PDBQT file was prepared by 
uploading the homology model into AutoDock Tools (Molecular Graphics Laboratory), 
removing all non-polar hydrogen atoms and saving the file as PDBQT. Next the search 
space was defined in AutoDockTools. The search space restricts where the movable 
atoms, including those in the flexible side chains, should lie. The spacing of the grid 
points was set to 1.000 Å and 35 grid points in all three directions were used. Therefore 
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the search space was cubic with a volume of in which each site measured 35 Å. Using 
important residues as a guideline, the center for x was chosen to be at X, for y at X and 
for z at X. The PDB file of L-arogenate was then converted into a PDBQT file by loading 
the PDB file into AutoDockTools, defining all bonds as rotable bonds and saving the file 
as PDBQT file. Docking was performed using AutoDock Vina, the defined centers for x, 
y, and z and an exhaustiveness of 20. (Molecular Graphics Laboratory) and the resulting 



















Chapter 3: Results 
3.1 Site-Directed Mutagenesis 
The tyrA gene from Synechocystsis sp. had been previously cloned into the 
pET24b expression vector by Dr. P. Hanic-Joyce between NdeI and XhoI restriction sites, 
maintaining its stop codon at the end of the gene so that no His-tag is incorporated into 
the sequence. The recombinant plasmid is approximately 6.1 kbp including a 5310 bp 
pET24b vector and an 840 bp insert (data not shown). The variant proteins were obtained 
using site-directed mutagenesis according to Stratagene’s QuickChangeTM protocol. 
Template plasmid was digested by incubation with DpnI so that only the mutagenized 
PCR products remained for transformation. PCR products were transformed into XL-10 
Gold E. coli cells that are able to repair the nicked mutagenic strand and plasmid 
preparations were performed on selected colonies. DNA sequencing of the inserts 
confirmed that the mutant plasmids carried only the desired base substitutions. 
 
3.2 Expression and Purification of WT Synechocystis AD and Variant Proteins 
 The following fifteen AD proteins were expressed and purified: Wild-type 
enzyme and the variants G221Q/S, M228D, G226Y, T117P, R213A, R217A, D171A, 
H112A, H170N, S178A, H179A, S178Q/H179A (double substitution), H264Q, 
H264Q/R265H/L266R (triple substitution). 
 The purification procedure adapted was based on the protocol originally 
developed for wild-type AD as outlined by Legrand and colleagues (48). Wild-type or 
mutant AD plasmids were transformed into BL21(DE3) cells which were then grown in 
LB medium supplemented with kanamycin, and protein expression was induced by the 
47 
 
addition of IPTG. Cells were disrupted by high pressure in the presence of protease 
inhibitors and the recombinant proteins were purified using Reactive Red 120 Agarose 
affinity chromatography at 4°C. The Reactive Red 120 resin is specifically designed for 
the purification of NADP
+
-dependant dehydrogenases by interacting with the cofactor 
binding pocket (70). The pooled purified protein fractions were dialyzed overnight at 
4°C, and AD was stored at -20°C in buffer containing 50% glycerol. Purified protein lost 
activity if frozen at -80°C in 15% glycerol and thawed. 
 Protein purification was monitored by measuring the A280 of eluted fractions and 
denaturing gel electrophoresis. A detailed analysis of each step of purification for the 
wild-type enzyme is shown in Figure 10. Over-expression of the recombinant AD 
enzyme is clearly seen in the cell lysate and the cell-free extract (lanes 2 and 3). 
However, some protein remained in the particulate fraction as noted in the analyzed cell 
debris which has been resuspended in buffer containing 2% SDS (lane 4). After applying 
the cell-free extract to the Reactive Red 120 Agarose column, no significant band 
corresponding to the monomer molecular weight of AD (~30 kDa) was observed in the 
flow-through (lane 5), indicating that all of the AD protein had bound to the column. 
After washing with ~15 column volumes of buffer (lane 6), a salt gradient was applied 
and the protein was eluted usually in fractions 3-8. The purification appears to yield 




Figure 10: SDS-PAGE analysis of wild-type AD purification. Lane 1: Protein molecular weight marker, 
Lane 2: Cell lysate (1/2 dilution), Lane 3: Cell-free extract (1/2 dilution), Lane 4: Cell debris in buffer 
containing 2% SDS, Lane 5: Red 120 Agarose flow-through, Lane 6: Red 120 Agarose wash, Lane 7-9: 
Pooled protein after Red 120 Agarose. Analysis performed on a 12% acrylamide gel. 
 



















2166 1673 0.77 100 1.0 
Flow-
through 
1570 97 0.06 5.8 0.1 
Pooled 153 1105 7.2 66.1 9.4 
Activity assays performed at 25°C at 2 mM NADP
+
 and 200 μM crude arogenate. aFrom 3L of cell culture, 
determined by Bio-Rad protein assay. 
 All AD variant proteins were purified using the same methodology as the wild-
type enzyme. Almost all AD proteins were purified to homogeneity (Figure 11) and 
behaved similarly during the purification process. The yields of purified protein typically 
varied between 40 – 70 mg/L of cell culture, with the exception was D171A, which 




Figure 11: SDS-PAGE analysis of purified AD variants. Lane 1: Protein molecular weight marker, Lane 
2: Wild-type AD, Lane 3: S178Q/H179A, Lane 4: G221Q, Lane 5: H264Q, Lane 6: H264Q/R265H/L266R, 
Lane 7: M228D, Lane 8: G226Y, Lane 9: G221S, Lane 10: T117P, Lane 11: R217A, Lane 12: R213A, 
Lane 13: S178A, Lane 14: D171A, Lane 15: H112A, Lane 16: H179A, Lane 17: H170N. Each of the 
protein samples were purified with Agarose Red 120 affinity chromatography prior to being analyzed on 
12% acrylamide gels. Approximately 6-10 μg of protein was applied in each lane. 
 
3.3 Electrospray Ionization Mass Spectrometry 
 The masses of the purified AD proteins were determined by ESI-Q-ToF MS to 
confirm that the correct amino acid substitutions were present (Figure 12). Overall, the 
theoretical and observed mass values of each recombinant protein were in good 
agreement (Table 4). The exception was D171A, whose deconvoluted spectrum did not 
reveal major peaks between 26500 and 32300 (data not shown). This result supports the 
data obtained from SDS-PAGE analysis, which shows that the enzyme is likely not stable 




Figure 12: Deconvoluted ESI-MS spectrum of wild-type AD enzyme. The peak shows the molecular 
weight of the monomeric form of the protein. 
 
Table 4: Summary of molecular masses of wild-type and variant AD proteins. 

















WT 30197.7 30193.0 4.7 R217A 30112.6 30110.4 1.8 
S178Q/H179A 30172.7 30170.3 2.4 R213A 30112.6 30109.5 2.9 
G221Q 30268.7 30266.7 2.0 S178A 30181.7 30180.3 1.4 
H264Q 30188.7 30186.5 2.2 D171A 30153.7 ND ND 
H264Q/R265H 
/L266R 
30212.7 30209.4 3.3 H112A 30131.7 30127.6 4.1 
M228D 30181.7 30180.8 0.9 H179A 30131.7 30128.2 3.5 
G226Y 30303.7 30301.7 2.0 H170N 30174.7 30171.9 2.8 
T117P 30193.7 30192.1 1.6 G221S 30227.7 30226.0 1.7 
* Expected mass based on the amino acid sequence was calculated using EXPASY-PeptideMass 
program which gives the average molecular weight of the deprotonated side chain. A mass difference 
of +/- 5 Da was considered to be acceptable. Values differ from sample to sample based on the 
particular instrument conditions and ambient temperature fluctuations on the day of analysis. ND 






3.4 Circular Dichroism Spectroscopy 
 3.4.1 Far-UV Circular Dichroism 
 Far-UV circular dichroism (CD) spectroscopy was used to determine if any of the 
amino acid substitutions within the AD variants had altered the global secondary 
structure of the protein. CD spectroscopy uses circularly polarized light, which is 
composed of both left-handed and right-handed components. Light in the far-UV region 
can be absorbed by the amide and carbonyl groups in a protein’s peptide backbone. 
Depending on the conformation adopted by the protein backbone, the amount of left- and 
right-handed circularly polarized light that is absorbed will vary (71), giving distinctive 
absorption bands for different global secondary structure arrangements. CD spectra were 
acquired between 200 – 260 nm at 20°C. Almost all AD proteins showed pronounced 
absorption minimal at 208 and 222 nm (Figure 13), which are characteristic of proteins 
with a high ɑ-helical content. The spectra of the variant proteins and wild-type enzyme 
are nearly super-imposable, which indicates that AD’s global secondary structures have 
not been perturbed by the amino acid replacements. The exception is D171A, whose 
signal is considerably less intense than that of the wild-type protein and other variants, 
presumably because there is much less than 6 μM in solution. 
The thermal stability of the wild-type AD and selected variants (Figure 14) was 
also probed by monitoring the change in ellipticity at 222 nm while increasing the 
temperature under conditions listed in section 2.15. The Tm of wild-type AD was 
determined to be 42.8°C by taking the 1
st
 derivative of the spectrum, with one other 
variant having a Tm within 0.5°C of this value. The variants that displayed markedly 
altered Tms (determined by the 1
st
 derivative of the melting curves) and unfolding 
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patterns were H264Q (36.1°C), H264Q/R265H/L266R (~50°C), and D171A. None of the 
enzymes completely lose their ɑ-helical content, even when heated to 95°C. 
 
 
Figure 13: Far-UV CD spectra of wild-type and variant AD enzymes. Variant proteins (~6 μM 
monomer) were exchanged into 50 mM potassium phosphate, pH 7.5. Spectra were recorded at 20°C in a 




Figure 14: Variable temperature far-UV spectra of wild-type and select variant AD enzymes. Each 
protein (~6 μM) was prepared in the same manner as described in figure 13. Spectra were recorded at 222 


































































3.4.2 Near-UV Circular Dichroism 
Near-UV CD spectroscopy was used to obtain information concerning the global 
tertiary structure of wild-type AD enzyme, and if it was perturbed by interaction with 
either of its substrates, NADP
+
 or L-arogenate (Figure 15). This absorption is a 
magnitude lower than that of peptide bonds, and generally occurs over the 260 – 320 nm 
wavelength range. The majority of this absorption is due to π – π* transitions within the 
aromatic chromophores, which corresponds to tryptophan, tyrosine, and phenylalanine 
residues. Furthermore, a signal occurs only if the chromophores are held rigidly in an 
asymmetric environment (72). CD spectra were acquired between 250 – 320 nm at 20°C. 
A significant peak was observed at 295 nm and a smaller shoulder at 285 nm, in keeping 
with the contribution of Trp or Tyr residues to the aromatic CD signal. No significant 
change in ellipticity was observed with the wild-type AD when titrated with high 
concentrations of L-arogenate. When titrated with NADP
+
, a change in ellipticity 
intensity was observed from 290 nm and below, increasing as the wavelength decreased. 
NADP
+
 begins to absorb at ~290 nm, however, exhibiting an absorbance maximum at 
259 nm. As such, the change in ellipticity is likely due to a change in the environment of 
NADP
+ 
 upon binding to AD. Buffer containing 20 μM of NADP+ or 750 μM L-









   
Figure 15: Near-UV CD spectra of wild-type AD. Spectra on the left show AD (49 μM) titrated with 
crude arogenate, and spectra on the right show AD titrated with NADP
+
. Spectra were recorded at 20°C in a 
0.2 cm path-length rectangular cell with a scan rate of 20 nm/min. Each curve represents the average of 7 
accumulations. 
 
3.5 Fluorescence Emission Spectroscopy 
 Fluorescence emission spectroscopy was used to determine if the amino acid 
replacements had altered the environment of the aromatic chromophores, tryptophan and 
tyrosine, in AD. The fluorescence emission spectra of most variants were comparable to 
the wild-type enzyme, with the exceptions of G226Y and D171A (Figure 16). G226Y is 
observed to have an increase in fluorescence intensity at an excitation wavelength of 280 
nm, but not 295 nm. This is consistent the introduction of an additional tyrosine residue 
into the protein’s primary sequence. The intensity of D171A at both excitation 
wavelengths is much lower than that wild-type protein, indicating that the amount of 
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Figure 16: Fluorescence emission spectra for selected AD enzymes. Left: Fluorscence emission spectra 
for variants at 20°C. Proteins (~6 μM monomer) were buffer exchanged into 50 mM potassium phosphate 
buffer, pH 7.5 and placed in a Varian 400 μL fluorescence micro cell (1.0 cm path-length). Excitation 
wavelength was fixed at 280 nm. The fluorescence emission was scanned from 300 to 400 nm using 
excitation and emission slit widths set at 5 nm. Spectra were corrected for buffer contribution. Right: 
Fluorescence emission spectra for selected proteins at an excitation wavelength of 295 nm. Spectra were 
recorded as described for the left panel. 
 
 The fluorescence spectra of wild-type AD enzyme were also recorded in the 
presence of increasing amounts of NADP
+
 (Figure 17). Stepwise changes in fluorescence 
emission intensity were observed, and an apparent Kd of 9.5 ± 3.9 μM was calculated. 
While the decreases in fluorescence intensity were relatively small, it was apparent by 17 
μM NADP+ no further signal were observed indicating that the AD is saturated with 
NADP
+
.  AD contains three tryptophan residues per monomer, but none are present in the 
putative L-arogenate binding site or the cofactor binding site. This decrease in intensity is 
likely attributed to minor quenching effects of cofactor binding. This observation was not 
















































Figure 17: Changes in fluorescence intensity of AD upon binding of NADP
+
. Left: The changes in 
intrinsic tryptophan fluorescence of wild-type AD (5 μM monomer) was observed by excitation at 295 nm 
and measuring the emission from 300 to 400 nm in 50 mM  potassium phosphate buffer, pH 7.5. NADP
+
 
was varied from a concentration of 0 to 29 μM. All spectra are corrected for buffer contribution, dilution 
effects upon titration and inner filter effects. Right: Fluorescence quenching is determined by plotting 
change in fluorescence at 335 nm as a function of total [NADP
+
]. An apparent Kd for NADP
+
 was 
calculated to be 9.5 ± 3.9 μM. 
 
3.6 Kinetic Studies of Wild-Type AD and Variants 
 In order to investigate the importance of selected active site residues of AD for 
enzyme function, kinetic assays were performed on the wild-type and variant proteins. 
For these studies, a crude preparation of L-arogenate (a kind gift from Carol Bonner) was 
used; its purity was estimated to be ~4%, determined by end point assay. Attempts to 
construct substrate saturation curves with L-arogenate or NADP
+
 as the variable substrate 
were unsuccessful, precluding the determination of the Michaelis constant (Km) and the 
turnover number (kcat). Although the Km for L-arogenate of AD from Synechocystis sp 
has been previously determined to be 93 μM (48) and 331 μM (15); a concentration of up 
to 3 mM L-arogenate in our assay did not yield zero order kinetic plot. We speculated 


































and/or with product analogs that would act as inhibitors of AD, therefore hindering 
enzyme function. Accordingly, specific activities of each variant were obtained (Table 5) 
and compared relative to that of the wild-type enzyme. Specific activity is described as 
the micromoles of substrate converted per minute per microgram of total protein. 
 The most common substitution employed in this collection of variants was 
alanine. Its small, non-polar properties eliminate hydrogen bonds or ionic interactions. 
Glutamine was used to introduce a longer, polar side chain group, while aspartic acid’s 
polar, charged side chain was used to replace a hydrophobic residue in the case of one 
variant. Backbone flexibility was investigated by introducing a proline. Another 
replacement for histidine was asparagine; the amide group preserves electrostatic 
interactions and hydrogen bonds associated with the imidazole ring. A number of amino 
acid replacements were made corresponding to residues within A. aeolicus PD or E. coli 
CM-PD in order to probe substrate specificity. 
 The variants that displayed the greatest decrease in specific activity (380 to 3200-
fold) were S178A, S178Q/H179A, G221Q, T117P, and R217A. G221S showed a 
moderate loss in activity (36-fold), while others showed activities comparable to the 
wild-type enzyme. H112A and D171A variants did not display any detectable activity. 
The activities for the variant proteins will be described further in the “Discussion”, by 
relating the substitutions to crystal structures, sequence alignments, literature and 
molecular docking. 
Activities of each of the variants were also determined under the following 












. No turnover was observed for the wild-type AD or 
any of the variants when prephenate and/or NAD
+
 were used as substrates. Additionally, 
there was no significant decrease in specific activities (5% or less) when variants were 
assayed in the presence of 500 μM L-Tyr, indicating that the enzymes are not sensitive to 
feedback inhibition.  
Table 5: Specific activities for wild-type AD and variants.  
Protein Specific Activity (umol/min/μg) Fold-decrease in 
Activity to WT AD 
WT 647 ± 55 1 
S178A 0.40 ± 0.03 1617 
H179A 143 ± 19 4.5 
S178Q/H179A 0.20 ± 0.01 3205 
M228D 612 ± 73 1.1 
G226Y 524 ± 80 1.2 











G221Q 1.7 ± 0.1 380 
G221S 18 ± 2 36 
T117P 1.6 ± 0.4 404 
R213A 178 ± 12 3.6 
R217A 1.1 ± 0.08 588 
H264Q 499 ± 23 1.3 
H264Q/R265H/L266R 437 ± 50 1.5 
Reactions were performed at pH 7.5 and 25°C.Values are the average of duplicate reactions. Substrate 
concentrations were fixed at 500 μM arogenate and 1 mM NADP+ in each assay. a No detectable activity 
when adding 60 μg to reaction mixture. 
 
3.7 Molecular Docking of Arogenate in the Active Site of AD from Synechocystis 
 The crystal structure of Synechocystis sp. AD was solved at pH 8.0 in complex 
with NADP
+
 (PDB ID: 2F1K), and is currently the only AD enzyme for which the crystal 
structure is available. Unfortunately, there are no structures of AD bound with L-
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arogenate. In order to gain further insight into the interactions of L-arogenate with 
Synechocystis sp. AD, attempts were made to dock the cyclohexadienyl substrate into the 
active site of AD using AutoDock Vina. Two criteria were established to evaluate the 
validity of the docking conformations: first, the C-4 ring hydroxyl group of L-arogenate 
must be close enough to the catalytic residue, H112, to form a hydrogen bond. Second, 
the C-4 hydrogen atom of L-arogenate must be close enough to the C-4 carbon of NADP
+
 
to facilitate hydride transfer. However, none of the conformations that were generated 
met either of these criteria. As such, an alternative strategy was adopted; when the 
backbone atoms of the NAD
+
-L-Tyr-enzyme and the NAD
+
-enzyme crystal structures of 
A. aeolicus Δ19PD were aligned, it was found that the structures possesed a root-mean 
square deviation (RMSD) of 0.6 Å. This small difference was visible in the active site, 
however, showed that the L-Tyr-complexed structure was in a slightly more closed 
conformation. Accordingly, it was hypothesized that this more “closed” form of the 
active site could be the preferable conformation for L-arogenate to dock. Homology 
models were generated using the crystal structure of A. aeolicus Δ19PD in complex with 
L-Tyr and NAD
+
 (PDB ID: 3GGG) with MODELLER 9v7 software. Ten homology 
models were generated, and their discrete optimized protein energy (DOPE) scores and 
RMSDs between the model and both the AD and Δ19PD crystal structures were 
evaluated (Table 6). The DOPE score is a statistical potential that takes into account non-
interacting atoms within a calculated area based on the structure of the template (74). A 
lower, more negative score indicates that the generated model is of higher quality. All ten 
models showed very similar DOPE scores and RMSDs to both crystal structures. Model 
nine, with the lowest RMSD, was selected for docking with AutoDock Vina. L-arogenate 
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was successfully docked into the active site of the homology model of AD; the two 
previously outlined criteria were met (Figure 20). For comparison purposes, L-arogenate 
was also modeled into the active site of the NADP
+
-bound crystal structure. 
Nine different L-arogenate conformations were generated simultaneously by the 
docking simulation. All of the conformations had binding affinities between -6.1 
kcal/mole and -4.8 kcal/mole. These differences are very small and cannot exclusively be 
used to evaluate the conformations. 
Table 6: Summary of RMSD and DOPE score values of AD homology models 
Model Number DOPE Score RMSD from AD 
(Å) 
RMSD from Tyr-
bound 19PD (Å) 
1 -26304 2.502 0.324 
2 -26135 2.492 0.373 
3 -26253 2.731 0.335 
4 -26401 2.773 0.347 
5 -26094 2.810 0.338 
6 -26645 2.199 0.386 
7 -26362 2.991 0.345 
8 -26267 2.662 0.326 
9 -26709 2.883 0.309 
10 -26154 2.229 0.394 
 
These binding affinities also suggest that it is possible for L-arogenate to exist in more 
than one of the proposed conformations, or that it can oscillate between a number of 
conformations while in solution.   
 A number of similarities as well as differences were observed between the 
residues interacting with L-arogenate when placed into the active site of NADP
+
-bound 
crystal structure of AD and docked in the homology model. When L-arogenate was 
placed into the active site of the crystal structure, the C4 ring hydroxyl of L-arogenate is 
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2.8 Å from H112, and the C-4 hydrogen of arogenate is 2.1 Å from the C-4 atom of 
NADP
+
. There are only two other residues that are close enough to potentially interact 
with L-arogenate directly. The first is S178, which maintains a distance of 3.4 Å away 
from the ring carboxyl group of L-arogenate. The second is the side chain of T117, which 
is 2.6 Å away from the side chain carboxyl group of L-arogenate. In the docked model, 
these residues are observed to interact with L-arogenate as well. In this structure, the ring 
hydroxyl of L-arogenate is 2.2 Å from H112, and the C4 ring hydrogen of L-arogenate is 
2.3 Å from the C4 atom of NADP
+
. Additionally, S178 is 3.1 Å away from the ring 
carbonyl group, and the backbone carbonyl of T117 is interacting with the amine group 
of L-arogenate, at a distance of 2.7 Å. The most striking observation is that R213 and 
R217 are both interacting directly with L-arogenate in this conformation. R217 is in the 
center of the active site, located 2.9 Å or 3.0 Å away from the ring carboxylate of L-
arogenate. Additionally, R213 is 2.8 Å or 3.0 Å away from the side chain carboxyl group 
of L-arogenate. In the NADP
+
-bound crystal structure, these two arginine residues are too 
far away from L-arogenate (Figure 21) to interact with this substrate. As such, the 
enzyme would have to undergo a considerable tertiary rearrangement upon the binding of 
L-arogenate in order for these residues to interact with the cyclohexadienyl substrate. 
Mutagenesis data supports the idea that both of these arginines play a role in enzyme 




Figure 18: Alignment of the backbone atoms of monomers of Synechocystis AD and A. aeolicus 
Δ19PD crystal cofactor bound structures. AD (PDB ID: 2F1K) is colored in blue while Δ19PD (PDB 
ID: 2G5C) is colored in purple. The RMSD of the alignment was 1.3 Å. Figure created using PyMOL (44). 
 
Figure 19: Alignment of the backbone atoms of the Synechocystis AD model nine and its Δ19PD 
template. The AD homology model (teal) and its template, Δ19PD in complex with NAD+ and L-Tyr 
(orange, PDB ID: 3GGG) were found to have an RMSD of 0.309 Å. Figure created using PyMOL (44). 
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 Figure 20: Active site of Synechocystis sp. AD with L-arogenate modeled into the active site of the NADP+-bound crystal structure and docked into the 
homology model. Left: L-arogenate (cyan) modeled into the active site of the experimentally determined NADP
+
-bound crystal structure of AD. The closest 
atoms on R217 and R213 are 9.8 Å and 15.1 Å away from the closest atom of L-arogenate, respectively.  Shown are possible interactions of L-arogenate with 
key residues of the active site. Right: L-arogenate docked into the active site of the AD homology model that had been generated using the NAD
+
-L-Tyr-bound 
crystal structure of A. aeolicus Δ19PD as a template. Possible interactions of L-arogenate and NADP+ with key residues are also shown. Images were generated 
in PyMOL (44), docking files were prepared using AutoDock tools and AutoDock Vina (75) as described in Materials and Methods. 
 
Figure 21: Comparison of arginine positions in the crystal 
structure and homology model of Synechocystis sp. AD. The 
backbone atoms of the crystal structure (labelled 2F1K) were 
aligned with those of the homology model of AD. The distances 
between the ɑ-carbons were measured to determine their 
differences for R213 and R217 to be present in the active site. 





3.8 Enzymatic Synthesis of L-arogenate 
 3.8.1 Expression and Purification of Prephenate Aminotransferase from 
Petunia Hybrida 
 Preliminary studies in were attempted to obtain L-arogenate from the 
accumulation media of S. typhimurium tyrA19 mutant which carried metabolic blocks in 
the L-arogenate pathway (Figure 9). We also followed the procedure reported by Rippert 
et al (56, section 3.8.2) to synthesize L-arogenate enzymatically from prephenate on a  
small scale using the crude preparations of prephenate aminotransferase (PAT) from the 
extracts of tobacco leaves. In our hands, both procedures yielded low amounts of impure 
L-arogenate and were very time consuming (data not shown). We chose to develop the 
enzymatic route further, using a recombinant form of PAT and a HPLC separation 
methodology to remove the nucleotide cofactors from the synthesis mixture. This will be 
described below. 
Prephenate aminotransferase (PAT) was expressed and purified using a protocol 
based on the report by Maeda and colleagues (54). The expression vector, pET24b, 
containing the gene encoding the PAT was transformed into BL21(DE3) cells, and then 
the cells were grown in LB medium supplemented with 50 μg/μL of kanamycin. Protein 
expression was induced by the addition of IPTG. Cells were lysed by high pressure while 
in the presence of protease inhibitors, and the recombinant protein was purified using Ni-
NTA affinity chromatography at 4°C. The purified protein was dialyzed overnight at 4°C. 
 The purity of the protein was verified at each step of the purification by 
denaturing acrylamide gel electrophoresis (Figure 22). Suprisingly, the presence of the 
over-expressed protein is not clearly visible in the cell lysate and the cell-free extract 
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(Lanes 2 and 3), although, some of the enzyme appeared to be associated with the 
particulate fraction (Lane 4). The lysate was applied to the Ni-NTA column and the flow 
through was collected. No relevant band at the weight corresponding to PAT can be 
observed in the flow through (Lane 5), suggesting that the majority of the recombinant 
hexa his-tagged enzyme bound to the column. After washing the column extensively with 
buffer (~15 column volumes, Lane 6), the protein was eluted with buffer containing a 
high concentration (300 mM) of imidazole. The molecular mass of His-tagged PAT is 
calculated to be 47.6 kDa, and is in agreement with the major band observed by SDS-
PAGE analysis (Lane 7).The purification protocol also yielded a higher molecular weight 
species (>66.2 kDa) as well as a protein smear just above the band for the recombinant 
PAT enzyme which might represent degradation products of the high-molecular weight 
contaminant (Lane 7).  
 
Figure 22: SDS-PAGE analysis of the purification of PAT from Petunia hybridia. Lane 1: Protein 
molecular weight marker, Lane 2: Cell lysate, Lane 3: Cell-free extract, Lane 4: Cell pellet dissolved in 2% 
SDS, Lane 5: Ni-NTA flow-through, Lane 6: Wash with 30 mM imidazole wash, Lane 7: pooled protein 
eluate with 300 mM imidazole wash. Analysis is performed on a 12% acrylamide gel. 
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3.8.2 Coupled enzymatic Assay for L-arogenate Synthesis 
Partially purified PAT can be used to enzymatically synthesize L-arogenate. PAT 
transaminates prephenate to L-arogenate in the presence of PLP and an amino donor, 
which can be either L-aspartic acid or L-glutamic acid (54). However, unlike the 
rearrangement of chorismate to prephenate by CM or the decarboxylation of prephenate 
to HPP by PD, the reaction catalyzed by PAT is reversible. Furthermore, none of the 
substrates or products of the reaction possess any distinctive spectrophotometric or 
flurometric properties,   
 
Figure 23: Coupled PAT assay for L-arogenate synthesis. Prephenate is reversibly transaminated to L-
arogenate by PhPAT in the presence of L-aspartate or L-glutamate. When L-aspartate is the amino donor, 
both oxaloacetate and L-arogenate are produced. The oxaloacetate can then be reversibly converted to 
malate in the presence of NADH and malate dehydrogenase (MDH). 
 
making the enzymatic reaction difficult to monitor continuously. As such, the reaction 
catalyzed by PAT was coupled to the reaction catalyzed by malate dehydrogenase 
(MDH), as described by Rippert and colleagues (56). The coupled assay is summarized in 
Figure 23, which shows that since NADH is a component of the assay, the progress of the 
reaction can now be monitored by observing the decrease in absorbance at 340 nm. 
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Furthermore, the production of L-arogenate is favoured by the conversion of oxaloacetate 
by MDH. 
 The coupled enzymatic reactions were performed at 37°C, the optimum 
temperature for PAT-catalyzed reaction (54). Until all the prephenate was consumed 
(ΔA340 of 0.33, 15-20 minutes), the reaction was stopped by snap-freezing in liquid 
nitrogen; aggregated proteins can later be separated by centrifuging of the thawed 
solution.  
 
Figure 24: Time-dependant consumption of NADH by MDH-catalyzed reaction. NADH disappearance 
is monitored spectrophotometrically at 340 nm as oxaloacetate is converted to malate. Oxaloacetate is a 
product of the transamination of prephenate to L-arogenate by PAT. Barium prephenate (5.4 mM) was 
converted the presence of 16.2 mM NADH (3x [prephenate]), 10 mM aspartate, 50 μM PLP, 12-17 μg 
PAT, and ~44 units MDH, in a volume of 1 mL. The A340 was monitored by making a 1:200 dilution into 
50 mM H2O. At this dilution, the concentration of NADH is 81 μM, which corresponds to an absorbance of 
0.55. The expected A340, if 5.4 mM prephenate is totally consumed, would decrease to 0.33, corresponding 
to a [NADH] of 54 μM after being diluted. N = 3 
 
3.9 Purification of Arogenate 
3.9.1 Analytical HPLC and LC-MS 
With the enzymatic conversion of prephenate to L-arogenate by the coupled 





malate, prephenate, oxaloacetate and PLP. Of these compounds, NADH and NAD
+
 are 
present in the highest concentrations and are the most problematic. The activity of AD is 
measured by following the time-dependent production of NADPH at 340 nm; 
contaminating NADH interferes with this measurement, and NAD
+
 in solution will 
degreade into compounds that also absorb at 340 nm, and this process is hastened by 
repeated freeze-thaw cycles (69). Therefore, it is essential that L-arogenate is separated 
from NADH and NAD
+
. HPLC is a standard method to separate small compounds, and 
has been used previously to separate arogenate from other compounds (54, 58). However, 
in these experiments, arogenate and any other compounds containing a primary amine 
were covalently derivatized with OPA for flurometric detection at 336 nm. Since the 
OPA-derivatized arogenate cannot be used for kinetic studies, the development of a 
HPLC method to separate unmodified L-arogenate from NAD
+
 and NADH was of clear 
interest. A separation protocol was developed first on the analytical scale, and then scaled 
up to the preparative level. 
Preliminary analytical HPLC separations were performed by using the protocol 
reported by Maeda and colleagues (54). Standard solutions of NAD, NADH, and 
prephenate (the latter was used as a standard for L-arogenate) were chromatographed 
seperately on a C18 column (5 μm, 80 Å, 150 x 3 mm) using a 15-min linear gradient of 
15-65% methanol in sodium phosphate buffer. Regrettably, all compounds eluted at 
approximately 2.1 min, and further attempts to resolve the compounds using different 
gradient and isocratic runs yielded similar results (data not shown). However, when the 
organic solvent was replaced with a 1-30% linear gradient of acetonitrile, NADH eluted 





Figure 25: Analytical HPLC chromatograms of standards and arogenate reaction mixture. A: 
Approximately 2.2 μg of prephenate (peak 1) and 6.6 μg of NADH (peak 3) were individually injected onto 
a C18 column and resolved with a 15-minute linear gradient of 1-30% acetonitrile and 20 mM sodium 
phosphate (pH 7.6) Peaks were detected at 210 nm. Prephenate was also acidified to produce 
phenylpyruvate by the addition of concentrated HCl and 2.2 μg was injected as well (peak 2). B: A 100 μL 
aliquot of a 1:400 dilution of the experimental arogenate reaction was injected onto the same column and 
compounds separated using the same conditions as the standards. Detection was performed at both 210 nm 
(blue) and 340 nm (red). C: A small amount of concentrated HCl was added to the sample and incubated 
for 20 min at room temperature. The reaction mixture after acidification was monitored at 210 nm (red), 
259 nm (dark purple), and 340 nm (green). A 100 μL aliquot of a 1:400 dilution of the acidified 




at 2.0 min (Figure 25A, peak 1) and phenylpyruvate (produced by the acidification of 
prephenate) eluted at 2.3 min (Figure 25A, peak 2). Next, HPLC separation was 
performed on the experimental arogenate reaction mixture under the conditions used to 
resolve the standards (Figure 25B). As shown in Figure 25A, two intense peaks at 6.3 
(Figure 25B, peak 5) min and 6.5 min (Figure 25B, peak 6) were observed likely 
corresponding to NAD
+
 and NADH, respectively. The peak at 6.5 min also displayed an 
absorbance at 340 nm, thus confirming the presence NADH. A small peak at 2.2 min 
(Figure 25B, peak 4) was observed, likely corresponding to the elution of arogenate, 
aspartic acid, and malate. In order to confirm the presence of L-arogenate in the reaction 
mixture, the sample was also acidified with HCl. The chromatogram of the acidified 
mixture is shown in Figure 25C. After the sample is acidified, two peaks are observed at 
5.8 and 6.4 min (Figure 25C, peaks 7 and 8). The injection was also monitored at 259 nm, 
and these two peaks absorb at this wavelength as well. The absorbance at 340 nm drops 
to a nearly undetectable level at 6.0 minutes after acidification, suggesting that NADH 
has decomposed under the acidic conditions. 
LC-MS was used to help identify the compounds from the acidified mixture 
(Figure 26). The presence of phenylalanine confirms the acidification of L-arogenate, for 
which a m/z peak was observed (Peak of 5.68 min, m/z 166.1, Figure 26B). The m/z peak 
corresponding to the mass of NADH was observed at 7.1 minutes (m/z 664.0, Figure 
26C), which is notably higher than previously observed. As the LC-MS was performed 
with MilliQ water rather than phosphate buffer, it is possible that this change in the 
mobile phase has altered the retention times of the compounds. Its intensity has also been 




Figure 26: Chromatogram of acidified experimental arogenate mixture and spectra of peaks 
corresponding to the masses of phenylalanine and NADH. A: The chromatogram of ions detected by the 
MS after being subjected to HPLC on the same C18 column used for previous separations. 100 μL of 1:400 
diluted experimental acidified arogenate mixture was injected onto a C18 column with a 15-minute linear 
gradient of 1-30% MilliQ H2O and acetonitrile. Major peaks are observed at 1.58, 4.55, and 5.68 minutes. 
B: The mass spectrum corresponding to the 5.68 minute peak of the chromatogram. The major peak has a 
m/z of 166.1, which corresponds to the molecular weight of phenylalanine. C: The mass spectrum 
corresponding to the 7.11 minute peak of the chromatogram. The major peak m/z peak of 664.0 




decomposition. The presence of peaks at 1.58 and 4.55 minutes (Figure 26A) further 
supports this view, as the peaks appear to correspond to the m/z peaks of degradation 
products. The peaks at 1.58 and 4.55 minutes had major m/z peaks of 277.1 and 143.1, 
respectively (data not shown). 
 
3.9.2 Preparative HPLC 
A diluted aliquot of the reaction mixture yielding L-arogenate was resolved by 
preparative HPLC using a XBridge C18 column (5 μM, 100 x 10 mm, Waters), kindly 
provided by Dr. Pat Forgione. Conditions were identical to those on the analytical scale 
experiments, with the exception that the flow rate was increased from 1.0 mL/min to 4.0 
mL/min. A small amount diluted sample mixture was first applied to observe the 
retention times of the compounds in the mixture on the preparative column (Figure 27). A 
similar pattern is observed, although the peaks are broader and the NAD
+
 and NADH 
peaks are observed at 4.5 and 5.1 min, respectively. Additionally, two small peaks are 
observed at elution times of 2.4 min and 3.1 min. When a larger amount of the reaction 
mixture is chromatographed separation is maintained between these two peaks (Figure 















Figure 27: Preparative HPLC chromatogram of arogenate reaction mixture.  A: An aliquot of  20 μL 
of a 1:2 diluted experimental L-arogenate mixture was injected onto a C18 column with a 15-min linear 
gradient of 1-30% 20 mM sodium phosphate (pH 7.6) and acetonitrile and detected at 210 nm (blue) as 
well as 340 nm (purple). B: An aliquot of 100 μL of the undiluted experimental L-arogenate mixture was 






Chapter 4: Discussion 
 The purpose of this study was to identify which amino acid residues which are 
important for the function of the monofunctional arogenate dehydrogenase from the 
cyanobacterium Synechocystis sp. Additionally, we attempted to develop a novel method 
to synthesize and purify arogenate using analytical techniques. This work presents the 
first mutagenesis studies on Synechocystis sp. AD.  In total, fifteen different variants were 
constructed and studied. Amino acid substitutions were selected based on the crystal 
structure of AD, docking simulations to a homology model of AD, and sequence 
alignments with other TyrA proteins. Some residues selected are highly conserved; these 
residues include H112, H170, D171, and R217. The majority of variants harboured single 
amino acid substitutions, along with a double substituted variant (S178Q/H179A) as well 
as a triple variant (H264Q/R265H/L266R). 
 It was found that all variants, with the exception of D171A, were purified to 
homogeneity using Reactive Red 120 agarose affinity chromatography and in good 
yields. The specific activity values were found to be reproducible. The results have been 
interpreted while referring to the crystal structure of AD, as well as the crystal structures 
and previous mutagenesis studies on other TyrA proteins. 
Serine 178 and Histidine 179 
 S178 and H179 are located in the middle of the active site of AD from 
Synechocystsis sp. Their proximity to L-arogenate after being both placed and docked in 
the active site suggests that these residues may play a role in substrate binding and/or 
catalysis, with S178 predicted to be of greater importance as its side chain is within 
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hydrogen-bonding distance from L-arogenate (Figure 28). Both S178 and H179 are 
conserved in several organisms (Figure 4), but are respectively a glutamine and alanine in 
other TyrA proteins, including CM-PD from E. coli and H. Influenzae. When this 
glutamine residue in E. coli CM-PD was replaced with an alanine residue, a decrease in 
kcat, without a marked change in Km for prephenate, was observed. In the monofunctional 
PD from A. Aeolicus, the equivalent residues for S178 and H179 are, S213 and H214, 
respectively. Both residues are involved in a hydrogen bonding network with S126, H147 
(the catalytic residue in PD), and WAT1, a highly conserved water molecule and were 
found to be important for prephenate binding, only showing modest decreases in kcat. (42) 
Of these residues, S213 was found to be more important than H214 in positioning WAT1 
with the C4-hydroxyl group of the ligand. However, in AD, no evidence for such a 
hydrogen bonding network is observed in the NADP
+
-bound crystal structure. S178 was 
converted to an alanine, to probe the possibility of any hydrogen bonds involving the side 
chain hydroxyl group of the residue. When L-arogenate was modeled into the NADP
+
-
bound crystal structure and docked into the homology model, they hydroxyl of S178 is 
proposed to form a hydrogen bond with the ring carboxyl group of L-arogenate (Figure 
28). The substitution to alanine resulted in a ~1600-fold drop in activity relative to the 
wild type enzyme, which indicates that it is essential in the catalytic mechanism of AD. 
Although S178’s interaction with the ring carboxyl group of L-arogenate may help lock it 




Figure 28: Possible interactions of S178 and H179 with L-arogenate. L-arogenate was placed into the 
active site of the NADP
+
-bound crystal structure of Synechocystis AD and the distances of S178 and H179 
from different atoms of L-arogenate were measured in PyMOL. Figure generated in PyMOL (44). 
A hydrogen bond formed between the side chain of S178 and the carbonyl group of the 
L-arogenate’s ring carboxyl moiety, might help to polarize the carbonyl oxygen thus 
promoting decarboxylation of the substrate; CO2 is one of the products of the reaction. 
The kinetic data greatly supports the hypothesis that S178 interacts directly with L-
arogenate and cold be involved in binding and/or catalysis. 
H179 was also individually converted to an alanine residue, and this variant only 
revealed a modest ~4-fold reduction in enzyme activity. As reflected in both the modeled 
and docked AD structures with L-arogenate, H179 appears to be too far away to interact 
directly with L-arogenate (Figure 28). Since H179 appears too far away from L-
arogenate, it is possible that the residue may play an indirect role in NADP
+
 binding. One 
of the residues that binds to NADP
+
 is S92, which is located on a flexible loop in the 
active site. A water molecule bridges H179’s imidazole nitrogen and S92’s side chain 
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hydroxyl group in the NADP
+
-bound crystal structure of AD. Additionally, the backbone 
amide and carbonyl groups of S92 appear to coordinate the ribose group of NADP
+
. 
Thus, this extensive hydrogen bonding network appears important to help coordinate 
NADP
+
 into the active site. 
S178 was also converted to a glutamine residue in combination with H179 to an 
alanine in the double variant. In this case, the length and flexibility of the side chain has 
increased, although glutamine retains the potential for hydrogen bonding interactions 
with L-arogenate and other enzymatic residues. If the S178Q substitution affected 
enzyme activity to the same degree as the S178A single variant, a ~6400-fold decrease in 
enzyme activity would be expected. However, a ~3200-fold reduction in enzyme activity 
was observed, which suggests that the S178Q substitution is not as detrimental to the 
architecture of the active site. It is possible that glutamine’s polar side chain can rescue 
some loss of enzyme function incurred by the ability to retain hydrogen bonding 
interactions with with L-arogenate and/or the water molecule. (Figure 28) The longer side 
chain length of glutamine compared to serine appears to be less favourable, due to 
increased flexibility and/or the introduction of steric clashes. An additional reason to 
study the S178Q/H179A double variant was to probe any changes in substrate specificity, 
since the glutamine-alanine pair is only observed in TyrA proteins with a high preference 
for prephenate. However, no activity for the double variant was detected in the assays 









Histidine 112 and 170 
 H112 is another key residue located in the core of the active site of Synechocystsis 
sp AD. It is highly conserved among all TyrA proteins, and has been identified as the 
catalytic hydrogen bond acceptor in a number of these proteins, including E. coli and H. 
influenzae CM-PD, as well as A. aeolicus Δ19PD (42). H112A is the only AD variant 
that lacks any detectable enzyme activity while maintaining global secondary and tertiary 
structural arrangements comparable to that of the wild-type enzyme as determined by 
spectroscopic measurements (Figure 13, 16). The conversion to alanine removes the 
H112’s ability to hydrogen bond with the C-4 hydroxyl group of L-arogenate. This 
hydrogen bond is hypothesized to be essential for the polarization of the ring hydroxyl 
group in order to facilitate electron transfer and hydride transfer. (48) As such, it is highly 
likely that H112 is the key catalytic hydrogen bond acceptor for the AD-catalyzed 
reaction. It remains to be determined if this histidine group is solely involved in catalysis 
and not binding the cyclohexadienyl substrate, as has been proposed for TyrA from A. 
aeolicus (43) and E. coli CM-PD (37). Determination of a Km or Kd for the interaction of 
L-arogenate with H112A is necessary. 
 H170 is another highly conserved residue in TyrA proteins. It is located directly 
above H112 in the NADP
+
-bound crystal structure of AD as well as the AD homology 
model, and appears to form an interaction with H112, as the imidazole nitrogen atoms of 
the two residues are 2.8 Å away from each other (Figure 29). The equivalent residue in A. 
aeolicus Δ19PD, H205 when changed to glutamine or leucine resulted in a 3-fold and 
500-fold decrease in kcat/Km, respectively (42). It was hypothesized that H205 (possibly a 




Figure 29: Possible interactions of H112, H170, and D171 in the NADP
+
-bound crystal structure of 
AD. Figure generated in PyMOL (44). 
catalytically competent conformation. As the positions of the histidine groups in the AD 
enzyme are almost identical to that of A. aeolicus PD, it is likely that H170 plays the 
same role. H170 was converted to asparagine, and hence, the potential to form this 
hydrogen bond with H112 might still be retained. The 250-fold decrease in specific 
activity of the H170N variant confirmed that H170 and H112 do interact but argued that 
an appropriate hydrogen bond was not retained with the glutamine substitution to help 
direct H112 for catalysis. It would be informative to measure and compare the activity for 
a H170L and H170Q variants, which would verify whether the presence of a hydrogen 





Aspartic Acid 171 
D171 is a highly conserved neighbour of H170. When D171 in Synechocystis AD 
was converted to alanine, the variant found to be was easily degraded, poorly expressed, 
and yielded a non competitive pattern of thermal unfolding as detected by far-UV CD 
(Figure 16). Interestingly, the compromised structure and function appear to be due to the 
depletion of different interactions, mainly this aspartic acid in AD. These observations 
mirrored the findings reported for the alanine variant of the equivalent residue in Δ19PD, 
D206. (42) In the NAD
+
-bound crystal structures A. aeolicus Δ19PD, the negative 
carboxyl moiety form a hydrogen bond with Nδ1 of H205, which in turn coordinate 
H147. The triad of H147, H205, and D171 had been hypothesized to play a role in 
substrate binding and catalysis. (42) In contrast, in the NADP
+
-bound crystal structure of 
AD, as well as the homology model of AD, D171’s side chain points away from the 
active site and instead interacts with the backbone amide of K94, the side chain and 
backbone of T95, the backbones of A168 and A175, and the side chain of N233. As such, 
it appears that D171 creates a number of interactions that helps maintain the structure of 
AD in a functional conformation (Figure 29).  
Methionine 228 
 M228 is one of several residues found forming a hydrophobic pocket in the 
bottom of the active site. This residue is not conserved in other TyrA proteins, and is 
often found as an aspartic acid, which is the residue observed in the CM-PD enzymes 
from E. coli and H. influenzae, as well as the PD from A. aeolicus. It was hypothesized 
by Legrand and colleagues that this residue played a role in substrate specificity, and that 
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it and the other residues forming the hydrophobic pocket (L225, M229, V182, V218) are 
necessary for ensuring that a concerted reaction mechanism occurs (48). 
 
Figure 30: Comparison of the location of the hypothesized hydrophobic pocket in the active site of 
Synechocystis AD. Left: L-arogenate is modeled into the active site of the NADP
+
-bound crystal structure 
of AD. Of the residues hypothesized to compose the pocket, M228 and L225 are 3.1 Å and 3.7 Å, 
respectively, away from one of the oxygen atoms of the ring carboxyl group of L-arogenate. Right: L-
arogenate is docked into the active site of the homology model of AD. None of the residues are in 
proximity to the ring carboxyl group of L-arogenate, the closest being L225, at a distance of 5.8 Å. Figures 
generated in PyMOL (44). 
This was originally proposed by Hermes and colleagues (38); a hydrophobic pocket 
facing the ring carboxyl group of arogenate could markedly shorten the lifetime of the 
dienone intermediate so that C-C cleavage occurs in the same transition state as hydride 
transfer. Legrand and colleague’s support for this hypothesis was based on their structural 
model of placing L-arogenate into the active site by replacing WAT43 with the ring 
hydroxyl group of arogenate and ensuring that the C-4 hydrogen atom was close enough 
to the C-4 carbon of NADP
+
 (Figure 8). When L-arogenate was modeled into the 
NADP
+
-bound crystal structure as well as the homology model, the ring carboxyl group 
was in proximity of this hydrophobic pocket, but was also interacting with the side chain 
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of S178 (Figure 30). This is in contrast to the docked homology model, in which the 
hydrophobic pocket is not observed within the proximity of L-arogenate. The M228D 
variant was characterized to see if the introduction of a polar, charged amino acid would 
disrupt the hydrophobic nature of this pocket, and affect enzyme activity. However, the 
specific activity of M228D was found to be comparable to that of the wild-type enzyme 
(Table 5), suggesting that if this hydrophobic pocket is required for a concerted reaction 
mechanism more residues within this pocket would need to be replaced. It is noteworthy 
that M228 is the closest residue to L-arogenate in the NADP
+
-bound crystal structure of 
AD (Figure 30). Considering the results of the modeling and docking studies combined 
with the structure and function importance of S178 presented in this thesis, it seems 
unlikely that this hydrophobic pocket is critical for catalysis to occur efficiently in AD. 
Arginine 213 and 217 
 In the NADP
+
-bound crystal structure of Synechocystis sp AD, R213 and R217 
are considerable distances away from the active site (Figure 8), with R213 located in 
close proximity to the C-terminal dimerization domain of the enzyme. Legrand and 
colleagues (48) were the first to report this after determining the crystal structure, and as 
such, dismissed the possibility for either residue playing a role in L-arogenate binding or 
catalysis, further pointing out that there is no R217 equivalent in plant ADs. The highly 
conserved nature of R217 made it an attractive target for mutagenesis studies in other 
TyrA proteins, such as E. coli CM-PD (R294), H. influenzae CM-PD (R297), and A. 
aeolicus PD (R250). In all three of these enzymes, this arginine was found to play an 
important role in prephenate binding (37, 42, 43, 49). The E. coli CM-PD variant, 
R294Q, yielded a 130-fold increase in the Km for prephenate (37); the A. aeolicus PD 
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variant, R250A, was observed to have a moderate increase in Km of 13-fold (43). The Km 
for prephenate in the H. influenzae CM-PD variant, R297Q, was the most severely 
affected of the three, showing a ~750-fold increase (49). The other arginine, R213, 
appears to be an alanine residue in the primary sequence of the CM-PD enzyme from 
both organisms, and is a lysine residue, K246, in A. aeolicus PD. Interestingly, the PD 
variant, K246A, was found to have a Km for prephenate that was 20-fold higher, 
suggesting that K246 is more important than R250 in prephenate binding.  
Although the NADP
+
-bound crystal structure of AD shows, R213 and R217 are 
too far away to interact with L-arogenate when this substrate was modeled into the active 
site (Figure 8), the AD variants, R217A and R213A, were constructed to determine any 
correlation with the previous functional studies on other TyrA protein variants. 
Surprisingly, R217A and R213A were observed to have a ~580-fold and ~4-fold drop in 
activity, respectively. As this result contradicts the information obtained from the 
available crystal structure of AD, molecular modeling and docking techniques were 
employed in order to attempt to rationalize how these residues, particularly R217, could 
play a role in maintaining enzyme activity. 
 We had carried out numerous docking simulations with the NADP
+
-bound crystal 
structure of AD, under different conditions, which included: introducing flexible 
residues; using different docking software; and increasing the exhaustiveness of the 
search to high levels. As previously mentioned, two criteria were used to judge the 
credibility of the docked conformations: the C-4 ring hydroxyl group of L-arogenate must 
be close enough to H112 so that they can hydrogen bond, and the C-4 ring hydrogen of 





so that hydride transfer can occur. However, no conformations were found that matched 
these two criteria. It had been previously observed that aligned backbone atoms of the 
NAD
+
-bound crystal structure of A. aeolicus Δ19PD with that of the NAD+-enzyme-L-
Tyr structure of the same enzyme possessed an RMSD of 0.6 Å. This difference was 
visible in the active site, where the amino acid residues in the L-Tyr-bound enzyme had 
“closed in” around this ligand. Thus, it is reasonable to hypothesize that this closed 
conformation may occur upon L-arogenate binding to AD, and that generating a structure 
of AD in this conformation may yield informative docking results. The crystal structure 
of Δ19PD in complex with NAD+ and L-Tyr (PDB ID: 3GGG) was then used as a 
template for homology modeling, and a homology model of AD was obtained that 
possessed a backbone RMSD of 0.3 Å with the template structure. Upon the first docking 
attempt with the homology model, a conformation satisfying the previously mentioned 
criteria was found. Upon closer inspection of the docked model, it was observed that both 
arginine residues are interacting directly with L-arogenate (Figure 20). R217 is now 
forming an interaction with the ring carboxyl group of L-arogenate, while R213 is 
interacting with both oxygen atoms of the side chain carboxyl group. These results 
suggest that the two residues play a role in binding L-arogenate, and that by converting 
the arginine residues to alanines should result in a drop in enzyme activity. While a 
reduction in specific activity observed, it cannot be confirmed whether the residues are 
involved in L-arogenate binding until values for the Km for L-arogenate are determined. 
 In order for R213 and R217 to interact directly with arogenate, AD would have to 
undergo a very large tertiary structural rearrangement relative to its NADP
+
-bound form; 
indeed, the ɑ-carbons of R213 and R217 shift 9.8 Å and 11.5 Å, respectively (Figure 21). 
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However, large tertiary structural rearrangements have been reported previously with 
enzymes that bind NADP
+
/NADPH. The crystal structures of the apo and NADPH-bound 
form of 2,5-diketro-D-gluconic acid reductase A (2,5-DKGR A) from Cornyebacterium 
were found to have markedly different tertiary structures, with regions of the active site 
undergoing coordinated conformational changes of up to 8 Å (77, 78). This 
rearrangement was hypothesized to occur so that upon NADPH binding, the enzyme 
would be in a catalytically competent form of 2,5-DKGR A. In the present study, near-
UV circular dichroism was performed first to see if such a structural change could be 
detected upon titration with arogenate or NADP
+
, but the no such change in the signal 
relative to that of the apo form of AD was observed (Figure 15). Additionally when the 
complimentary technique of fluorescence emission spectroscopy was also used, no 
change in the emission intensity was observed at an excitation wavelength of 295 nm 
upon titration with L-arogenate. Small but significant decreases that mimicked saturation 
of a receptor by a ligand were observed upon titration with NADP
+
 (Figure 17). The 
closest tryptophan residue (3 per monomer) is located 11 Å away from the NADP
+
 
binding site in the cofactor liganded crystal structure. Consistent with NADP
+
 quenching 
the fluorescence intensity upon binding and/or perturbing the environment of the 
tryptophan residues participating in the emission spectra, although we could not 
determine a Km for either substrate from the kinetic studies in this thesis, the change in 
fluorescence intensity yielded a Kd value of 9.5 ± 3.9 μM (Figure 17) for the interaction 
of NADP
+
 with the enzyme. This value is similar to the Km of NADP
+
 determined by 
Legrand et al. (48) of 9 μM and is therefore in keeping with the hypothesis that AD 
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follows a rapid equilibrium random kinetic mechanism. In this mechanism, Km is a good 
approximation of Kd. 
Glycine 221 
 G221 is located at the bottom of the active site, and had been previously 
hypothesized by Legrand and colleagues (48) for being a key residue in determining the 
AD’s strict substrate preference for L-arogenate. They argued that G221’s small chain 
length is more accommodating for L-arogenate’s more bulky amine group than the 
equivalent glutamine residues found in the E. coli and H. influenza CM-PD enzymes. 
Additionally, this residue is a serine in a number of other PD enzymes, including that 
from A. aeolicus, whose corresponding residue is S254. In the crystal structure with  
 
 
Figure 31: Potential interactions formed by G221 after being converted to glutamic acid in both the 
modeled and docked structures. G221 was converted to a glutamic acid residue using the “mutagenesis” 
feature in PyMOL. In the crystal structure with arogenate modeled into the active site (left), the new Q221 
residue is close enough to potentially interact with L-arogenates’ side chain. However, in the docked 
homology model (right), Q221 is moved directly into the active site, but remains distant from L-arogenate. 
Figures generated using PyMOL (44). 
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L-arogenate modeled into the active site as well as the L-arogenate-docked homology  
model, the amine group of L-arogenate is the atom closest to G221, is still 9.7 Å and 11.5 
Å away, respectively. Thus, there appears to be ample space for L-arogenate to enter the 
active site. In the L-arogenate-docked homology model of AD, when G221 is changed to  
glutamine, the residue is still too far away to form an interaction with L-arogenate 
(Figure 31).  However, in the crystal structure with L-arogenate modeled into the active 
site, when G221 is changed to glutamine, the side chain resides 3.3 Å away from L-
arogenate’s amine group (Figure 31). The AD variants, G221S and G221Q were 
characterized to determine whether these replacements play any role in substrate 
specificity. Surprisingly, G221Q and G221S were observed to have a ~380-fold and ~36-
fold decrease in specific activity, respectively. The reduction in activity with the G221S 
variant is difficult to explain because its side chain doesn’t move much closer to L- 
arogenate in either model (Figure 31). It is possible that the introduction of residues 
capable of hydrogen bonding results in an interaction with the amine group; the 
glutamine in Figure 31 is a distance of 3.3 Å away from the amine. This interaction could 
hinder enzyme activity by slowing down product release, affecting catalysis. The 
hydroxyl side chain of serine is further away, making the formation of this interaction 
more difficult, which would explain why the G221S variant is 10 times more active than 
G221Q. Since this interaction is not observed in the arogenate docked homology model, 
this would also suggest that either the position of G221 in this model is incorrect, or that 
the enzyme returns to a similar conformation as the NADP
+
-bound form after the reaction 
has occurred, and manages to interact with tyrosine before it leaves the active site. It 
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would be worthwhile to investigate this further by converting G221 to a leucine; if a drop 
in activity remained, then this would suggest that this is due to a steric clash. 
Threonine 117 
 T117 is located on a flexible loop, and composes a portion of the active site. T117 
appears to be interacting with L-arogenate in both the modeled NADP
+
-bound crystal 
structure and the docked homology model (Figure 20), although with different atoms. In 
the crystal structure, the backbone carbonyl and side chain hydroxyl groups are close 
enough to the side chain carboxyl group of L-arogenate to interact. In the homology 
model, the backbone carbonyl and amine groups of T117 are the groups close enough to 
the docked L-arogenate to interact with its side chain amine group. While the side chain 
hydroxyl group of T117 also participates in NADP
+
 binding by forming a hydrogen bond 
with the carbonyl group of the nicotinamide moiety. In order to investigate these potential 
backbone interactions, T117 was replaced by the cyclic imino acid proline to see if the 
imposed rigidity of the substitution on the loop region would affect the function of AD. A 
~400-fold drop in specific activity (Table 5) was observed relative to wild-type AD.  This 
suggests that increasing the rigidity of this active site loop affects enzyme activity 
negatively. In support of this view, when the equivalent residue in A. aeolicus Δ19PD 
(T152) was changed to a proline residue, the efficiency constant for the reaction 
catalyzed by this variant was reduced by a factor of 100, with equal but opposite effects 
on kcat (decrease) and Km (increase) for prephenate; when NAD
+
 was the variable 
substrate, a 10-fold decrease in kcat was observed, with a significant increase to the Km 
(42). Interestingly the carbonyl group of T152 was shown to interact with the amine of L-
Tyr. (Figure 7) Thus, it is possible that T117 in AD could be involved in catalysis and the 
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binding of both substrates, L-arogenate and/or NADP
+
. Converting T117 to a glycine 
residue to increase flexibility in the loop could be worthwhile to further investigate the 
importance of flexibility with this loop. 
Histidine 264, Arginine 265, and Leucine 266 
 H264, R265, and L266 are all located in on ɑ-helix ɑ11 that composes part of the 
C-terminal dimerization domain of AD. These residues were targeted for mutagenesis 
based on the controversy regarding the effect of L-tyrosine on AD activity. Bonner and 
colleagues (15) had reported previously that AD was sensitive to end-product inhibition, 
and determined a Ki of 70 μM by kinetic inhibition studies. Legrand and colleagues (48) 
observed no L-tyrosine inhibition with concentrations up to 500 μM, in agreement with 
what was observed in this study. The “wild-type” enzyme which Bonner and colleagues 
characterized was reported by Legrand and colleagues to contain four amino acid 
changes: H264Q, R265H, R266L, and Q268L. In an effort to try to explain this 
discrepancy, three of these four amino acid substitutions were made on two different 
variants; one variant contained a single substitution, H264Q, while the second variant 
contained H264Q, R265H, and R266L. The structure of the NADP+-bound AD shows 
that of the four residues targeted, the side chain ofH264 interacts with the side chain of 
E224 on the adjacent monomer. While E224 is not part of the active site, it is located on 
helix ɑ6 that is part of the active site and this changes the position of this helix, which 
could in turn affect AD’s sensitivity to L-Tyr. This hypothesis was not supported by the 
kinetic results; it was observed that the wild-type enzyme along with H264Q and 
H264Q/R265H/L266R were L-tyrosine insensitive up to a L-tyrosine concentration of 1 
mM. Thus, the discrepancy in the two published reports remains a mystery. Interestingly, 
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although the variants were effective catalysts, the C-terminal region affected the 
enzyme’s thermal induced unfolding properties; H264Q had a Tm value 6°C lower than 
the wild-type enzyme and the triple variant unfolded was considerably less cooperative. 
Arogenate Synthesis and Purification 
 Another purpose of this study was to develop a reliable method to synthesize and 
purify L-arogenat for use in kinetic and biophysical studies. Synthesis of L-arogenate was 
performed enzymatically using PAT from Petunia hybridia. This assay was done 
similarly to Rippert and colleagues (56), whom performed the assay on a smaller scale 
and used a crude PAT extract obtained from tobacco leaves.  
The expression of the PAT was performed in the same manner as the wild-type 
and variant AD enzymes, although the yield of the purification of PAT, ~6 mg/3L of 
culture, was much lower than the AD enzymes. Expression of the PAT was previously 
performed in E. coli Rosetta
TM
 cells (54), which are BL21 derivatives designed to 
enhance the expression of eukaryotic proteins that contain codons rarely used in E. coli; 
the cells contain a compatible plasmid that express tRNAs for AGG, AGA, AUA, CUA, 
CCC, and GGA codon. The absence of this plasmid is likely the reason for the low 
expression level seen in E. coli BL21(DE3) cells. However, for purposes of this study, 6 
mg of partially purified PAT was more than sufficient. The enzyme was purified by Ni-
NTA affinity chromatography. The pooled PAT fractions contained a high molecular 
weight contaminant, approximately 75 kDa in size. However, the PAT was functional in 
the presence of this contaminant, and so further purification steps were not pursued. 
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 The conversion of prephenate to L-arogenate enzymatically by PAT could be 
readily predicted and followed spectrophotometrically by oxaloacetate produced by the 
PAT-catalyzed transamination reaction in an NADH-dependant reaction with malate 
dehydrogenase (Figure 23, 24). As NADH used in this coupled enzymatic synthesis 
interferes with the NADP-dependant reaction catalyzed by AD, we successfully 
developed an HPLC method using an acetonitrile gradient in phosphate buffer to 
potentially separate the NAD
+
 and NADH from the other components of the reaction 
mixture (L-aspartate, oxaloacetate, malate, and L-arogenate). This is performed under 
neutral pH conditions that would note decarboxylate L-arogenate. 
In efforts to follow L-arogenate production by acidification of the synthesis 
reaction mixture, it was observed that NAD
+
 and NADH likely decomposed under the 
acidification conditions (Figure 25C). Any absorbance at 340nm due to reduced cofactor 
concentration was eliminated. Some of these peaks correspond to phenylalanine, as well 
as breakdown products of NAD
+
 and NADH are aromatic, as both peaks were detected at 
259 nm (Figure 25C). Figures 25A and 25B show that NAD
+
 and NADH elute from 
analytical HPLC at 6 – 6.5 min and much later than other reaction components. Further 
analysis by LC-MS of the acidified reaction mixture confirmed the presence of 
breakdown products of the nucleotide cofactors and additionally revealed that the 
reaction mixture did contain L-arogenate.  
LC-MS was attempted on the experimental L-arogenate sample prior to 
acidication; however, despite detection being observed on the LC chromatogram, 
detection was not observed on the MS chromatogram (data not shown). Normally, the 
mobile phase will contain formic acid to improve the detection and resolution observed 
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on the MS. When the neutral experimental arogenate sample is run on the LC-MS, 
neither acetonitrile or MilliQ H2O buffer contains formic acid, otherwise arogenate will 
decarboxylate. After acidification, this is no longer a concern, and the sample is run with 
each component of the mobile phase containing 0.2% formic acid. This suggests that the 
presence of acid in the mobile phase is critical for proper ionization to occur. 
 The MS chromatogram reveals four distinctive peaks, observed at: 1.58 minutes, 
4.55 minutes, 5.68 minutes, and 7.15 minutes (Figure 26A). The 5.68 minute peak was 
found to have a major m/z peak of 166.1, which corresponds to the exact mass of 
phenylalanine. This confirms the presence of phenylalanine in the mixture, derived from 
L-arogenate, which had been present prior to acid treatment. The 7.15 minute peak was 
found to have a major m/z peak of 664.0, which closely corresponds to the exact mass of 
NAD
+
, which is found to be 664.1 g/mol. There are two characteristics about this peak 
that differ from the sample prior to acidification: the first of which is the peak is much 
less intense, and the retention time has increased by approximately 1 minute. The low 
intensity of the peak corresponding to NAD
+
 supports the HPLC chromatogram, which 
indicates that the nucleotide has degraded under the acidic conditions. The change in 
retention time is likely due to the change in mobile phase; MilliQ H2O is used in place of 
phosphate buffer for LC-MS experiments. It’s possible that in the presence of phosphate 
buffer, the negatively charged phosphate ion will be attracted to the positive charge of the 
NAD
+
 molecule, and could make the molecule more hydrophilic than usual. The 
remaining peaks, observed at 1.58 and 4.55 minutes, were found to have major m/z peaks 
of 277.1 and 143.1, respectively. These signals are more difficult to explain, but appear to 
be degradation products of NAD
+





compound with the largest molecular weight is PLP, which is 247.1 g/mol; therefore, the 
compound with a m/z ratio of 277.1 must have come from a heavier compound, which 
would have to be NAD
+
/NADH. 
Figure 27 shows that the separation of NAD+/NADH (peaks 3 and 4) from the 
reaction components could be achieved also on a preparative scale. The fractions 
corresponding to peaks 1 and 2 (Figure 27) were collected and frozen at -80°C. The 
identities of these two peaks have yet to be determined. If L-arogenate, or its 
decarboxylation product phenylalanine after acid treatment, is detected in one of these 
fractions, then arogenate can be readily prepared and purified by the methodology 
described in this study. The next step would be to scale up the reaction mixture volume, 















Chapter 5: Summary and Future Work 
 We have found a number of active site residues that play a role in the function of 
Synechocystsis sp. AD. In order decipher whether these residues play a role in catalysis 
and/or substrate binding, Km and kcat parameters must be obtained for the wild-type 
enzyme and all variants, and remains a priority with regard to future work. Nonetheless, 
some key insights have been made into the nature of ADs’ active site. We confirmed that 
H112 is the catalytic residue, and is essential for enzyme function. H170 is important for 
enzyme function likely for an interaction it forms with H112, in order to help maintain it 
in a catalytically competent conformation. This interaction is observed in the crystal 
structure, and supported by previous mutagenesis studies on the equivalent residue in 
homologous enzymes. D171 likely plays a key role in maintaining enzyme stability, by 
forming backbone interactions with its side chain group, as well as its backbone atoms as 
well. Future mutagenesis studies could be worthwhile to determine whether factors such 
as charge and chain length are important determinants for these interactions. S178 
appears to be one of the most important residues, and likely plays a role in binding 
arogenate to the active site, according to modeling and docking simulations. Furthermore, 
it may play a role in catalysis as well, due to its potential interaction with arogenates’ ring 
carboxyl group. The conversion of H179 only modestly decreased enzyme activity, but 
when it was converted in unison with S178, an additive effect in enzyme activity was 
observed. H179 may affect enzyme activity by affecting NADP
+
 binding through the 
existence of a hydrogen bonding network involving a water molecule and S92, rather 
than arogenate binding. Surprisingly, R213 and R217 were both found to affect enzyme 
activity, with R217 having a more severe effect than R213. Homology modeling and 
95 
 
docking simulations suggested that this is due to the residues’ roles in binding arogenate 
to the active site. G221’s short side chain appears to be important for enzyme function, 
and could be necessary for arogenate to efficiently make its way into the active site. It 
could also potentially affect catalysis by slowing down the process of product release. 
M228, on its own, was not found to be important for enzyme function upon its 
conversion to a polar and charged residue. Further mutagenesis studies involving the 
conversion of additional hydrophobic residues, previously hypothesized to compose an 
important hydrophobic pocket, to polar residues, could be interesting to investigate this 
hydrophobic pocket further. T117 was also confirmed being important for enzyme 
function despite not being highly conserved. Converting T117 to a glycine could be 
insightful regarding the importance of flexibility of the loop upon which T117 is located. 
While H264 appears to play a role in the enzymes’ thermal stability, neither the single or 
triple-substituted variant was found to be tyrosine sensitive. 
 Arogenate appears to have been synthesized by coupled enzyme assay and 
separated from its major contaminants, NAD
+
 and NADH, by HPLC on both the 
analytical and preparative levels. LC-MS analysis detected the presence of phenylalanine 
in the acidified mixture, which corresponds to arogenates’ presence in the mixture prior 
to acidification. Fractions corresponding to two peaks that would contain arogenate were 
collected from preparative separation and need to be analyzed by direct injection onto the 
MS. Provided that the presence of arogenate is determined, the next step would be to 
scale up the size of the enzymatic arogenate synthesis reaction, so that sufficient amounts 
of purified arogenate can be obtained, as kinetic analysis of AD is a top priority. 
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 Once suitable arogenate can be obtained and kinetic parameters can be 
determined, further mutagenesis studies can be pursued to further decipher AD’s active 
site. In this study, the mutagenesis strategy that was adopted involved targeting a large 
number of residues within the active site, rather than focusing on a few residues and 
extensively characterizing them by making multiple conversions. Now that a number of 
important residues have been successfully identified, these key residues can be converted 
to other residues to determine the details about the interactions and roles they play. More 
extensive protein engineering strategies could also be explored in order to further 
investigate the issue of substrate specificity. Rational approaches, such as chimera 
construction, could be pursued. Rational design is often high risk, but the process can be 
improved considerably with the aid of predictive computer algorithms; the SCHEMA 
algorithm (79) calculates the likelihood of a chimera protein being able to fold into its 
native conformation, and hence helps increase the chance of finding functional chimeras. 
Random mutagenesis approaches could provide considerable insight into the 
determinants for substrate specificity by selecting for AD mutants that can turn over 
prephenate as a substrate. However, this requires the availability of a high-throughput 
selection assay. Such an assay is currently under development by exploiting the 
phenotype of the knockout E. coli strain, KB357, which is unable to synthesize L-Tyr or 
L-Phe.  
Similarly, the issue of tyrosine inhibition could be further explored by performing 
mutagenesis on the active site of the AD from Arabidopsis thaliana, which is reported to 
be highly sensitive to tyrosine inhibition. Determining which residues participate in 
inhibition, as well as the mechanism of inhibition, would provide insight as to similarities 
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and differences between the two AD enzymes, and possibly an explanation as to why AD 
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